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ABSTRACT		 The	larvae	of	Xenopus	laevis	can	naturally	regenerate	a	lost	lens	from	the	outer	cornea	epithelium	after	it	is	triggered	to	do	so	by	signals	from	the	neural	retina.	The	signals	have	been	widely	studied,	and	FGFs	are	reported	to	play	a	key	role	in	causing	the	cornea	to	transform	into	a	lens.	However,	the	factors	that	make	the	cornea	itself	competent	to	respond	to	these	signals	are	unknown.	Understanding	the	factors	that	underlie	regeneration	competency	is	the	key	to	granting	otherwise	ordinary	tissues	the	ability	to	regenerate,	including	in	our	own	bodies.	Thus,	the	focus	of	this	work	has	been	on	the	cornea,	in	order	to	unravel	the	signaling	schemes	that	operate	within	it.		The	Retinoic	Acid	(RA)	signaling	pathway	is	a	major	cellular	signaling	pathway	involved	in	development,	organogenesis,	and	regeneration.	It	was	strongly	implicated	in	the	regeneration	of	the	lens	in	another	model	system,	the	newt,	where	retinal	signals	trigger	the	dorsal	region	of	the	iris	to	differentiate	and	give	rise	to	a	lens.	Antagonism	of	RA	signaling	was	shown	to	inhibit	lens	regeneration,	demonstrating	its	necessity.	We	investigated	whether	the	same	was	true	in	Xenopus.	We	inhibited	RA	signaling	using	inhibitors	of	RA	synthesizing	enzymes,	and	of	the	RAR	nuclear	receptors.	In	all	cases	we	found	there	to	be	no	effect	on	regeneration.	We	validated	that	the	drug	treatments	were	meaningful	by	observing,	via	qPCR,	a	decrease	in	the	expression	cyp26a1,	a	well-established	marker	of	RA	signaling.	We	also	examined	the	expression	of	multiple	RA	signaling	pathway	members	both	in	control	corneas	and	in	corneas	harvested	in	the	first	4	days	following	lentectomy.	In	both	these	normal	and	regenerating	tissues	we	found	the	expression	of	cyp26	genes,	which	encode	the	RA	metabolizing	enzyme	CYP26.	In	light	of	this	finding,	we	assessed	whether	CYP26	was	necessary	for	supporting	lens	regeneration.		In	contrast	to	the	experiment	described	above,	exogenous	addition	of	an	antagonist	of	CYP26	greatly	inhibited	lens	regeneration.	Likewise,	a	synthetic	retinoid	that	activates	RA	signaling	without	being	metabolized	by	CYP26	also	
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inhibited	regeneration,	as	did	excess	exogenous	RA.	In	all	treatments,	we	observed	profound	upregulation	of	the	RA	signaling	marker	cyp26a1.	Taken	together,	we	demonstrated	that	the	action	of	CYP26	is	necessary	for	lens	regeneration,	which	implies	a	necessity	to	attenuate	RA	signaling	by	metabolism	in	order	for	lens	regeneration	to	occur	in	Xenopus.	This	represents	a	species-specific	difference	in	the	signaling	schemes	that	underlie	lens	regeneration,	and	a	previously	undescribed	role	for	CYP26	in	regeneration.	Using	immunohistochemistry	and	a	whole-cornea	mounting	technique,	we	observed	the	widespread	expression	of	RALDH	and	CYP26	enzymes	within	the	corneal	layers	under	a	confocal	microscope.		We	next	investigated	the	possible	mechanistic	roles	of	CYP26	that	could	explain	its	necessity	in	lens	regeneration.	We	assessed	whether	RA	signaling	regulated	cell	proliferation	in	the	cornea	by	quantifying	changes	in	cell	division	following	various	treatments.	We	found	that	CYP26	antagonism,	but	not	exogenous	retinoids,	lead	to	a	significant	reduction	in	cell	proliferation.	This	finding	lead	us	to	examine	the	possibility	that	CYP26	may	actively	generate	RA-metabolites	whose	absence	would	lead	to	reduced	corneal	cell	division,	and	therefore	stunted	regeneration.	This	would	suggest	a	mechanistic	role	of	CYP26	as	a	ligand	generator,	rather	than	simply	an	RA	signaling	attenuator.	We	tested	this	by	supplementing	ex	vivo	cultures	with	both	Liarozole	(a	CYP26	antagonist),	and	4-oxo-RA	(a	metabolic	product	of	RA).	These	co-treated	cultures	failed	to	regenerate	lenses,	just	like	Liarozole-only	controls.	Additionally,	4-oxo-RA	supplementation	does	not	recover	the	loss	of	cell	division	that	occurs	from	Liarozole.	We	also	documented	that	4-oxo-RA	causes	the	upregulation	of	cyp26a1	in	corneas,	confirming	its	transcriptional	effects.	Taken	together,	it	appears	that	CYP26	likely	plays	a	role	to	simply	attenuate	RA	signaling,	and	does	not	act	to	generate	novel	signaling	ligands.	We	additionally	examined	the	possibility	that	RA	signaling	modulates	the	expression	of	key	corneal	stem	cell	markers	like	sox2,	oct60,	and	p63.	We	examined	their	expression	under	RA	antagonism	and	stimulation,	and	found	that	CYP26	does	not	likely	mediate	its	effects	through	such	markers.	However,	we	discovered	that	RA	can	attenuate	the	
  iv 
expression	of	the	eye	markers	fgfr2	and	pax6	in	the	cornea,	and	CYP26	may	prevent	this	attenuation	during	regeneration.			Lastly,	we	looked	at	whether	CYP26	was	involved	in	early,	late,	or	all	stages	of	lens	regeneration	by	varying	the	timepoints	at	which	compounds	were	added	to	ex	vivo	cultures.	We	discovered	that	CYP26	activity	is	only	important	during	hours	12-48	post-lentectomy.	This	suggests	a	role	in	establishing	or	maintaining	lens-competency	in	the	cornea,	rather	than	lens	cell	differentiation/maturation.	In	summary,	the	principal	finding	of	these	studies	is	that	CYP26	is	important	for	
Xenopus	lens	regeneration,	likely	by	acting	to	attenuate	RA	signaling	during	early	regenerative	events.	
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CHAPTER	1	
	
Introduction			 A	remarkable	observation	was	made	by	Overton	and	Freeman	in	1960,	that	if	one	removed	the	ocular	lens	from	the	frog	Xenopus	laevis,	within	a	few	days	a	new	one	would	grow	to	replace	it	that	was	histologically	indistinguishable	from	the	original.	At	the	time,	it	was	thought	that	the	new	lens	was	derived	from	the	animal’s	iris,	but	it	was	soon	understood	that	the	source	of	the	regenerated	lens	was	actually	the	cornea	(Freeman,	1963;	Freeman	and	Overton,	1961).	Tools	for	understanding	the	cytological	and	histological	events	behind	this	observation	were	limited	at	that	time,	but	through	methodic	and	diligent	observation	of	thin	sections	under	a	light	microscope,	Freeman	could	observe	that	the	regenerated	lens	formed	from	the	innermost	layer	of	the	bi-layered	outer	cornea	epithelium	(Freeman,	1963).	Although	the	exact	term	was	not	coined	until	1974	(Selman	and	Kafatos,	1974),	the	cornea	tissue	was	said	to	undergo	a	process	of	“transdifferentiation”	to	form	a	new	lens,	meaning	events	of	de-differentiation	and	re-differentiation	of	cornea	cells	precede	the	genesis	of	a	new	lens.			We	have	since	come	to	learn	that	the	outer	cornea	epithelium	is	not	simply	bi-layered,	but	actually	has	three	distinct	layers	when	observed	under	a	confocal	microscope—a	deeper	third	layer	in	immediate	proximity	to	the	lens	was	invisible	to	Freeman’s	observation	methods,	and	contains	a	fibrillar	matrix	and	scattered	cells	(Perry	et	al.,	2013).	A	modern	standard	of	evidence	also	disputes	whether	the	lens	is	truly	derived	from	“transdifferentiated”	cornea	cells,	but	rather	from	resident	cornea	stem	cells.	The	early	studies	of	Xenopus	lens	regeneration	set	the	stage	for	a	long	line	of	work	that	would	follow,	including	the	work	described	in	these	pages,	and	we	are	now	beginning	to	understand	the	molecular	signaling	events	that	regulate	this	process.			
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1.1	Vertebrate	lens	regeneration	is	clinically	important		 An	estimated	38	million	people	are	blind	globally,	the	leading	cause	of	which	is	the	presence	of	cataracts	(Thylefors	et	al.,	1995),	accounting	for	nearly	half	of	all	blindness	(WHO,	2000).	A	cataract	is	the	presence	of	an	opaque	lens	in	the	eye	after	the	lens	has	lost	its	transparency	slowly	over	years	of	aging,	or	abruptly	due	to	traumatic	injury.	In	the	United	States,	nearly	half	of	all	people	will	have	cataracts	by	age	75	(NEI,	2010).	The	amount	of	money	spent	on	cataracts	in	the	United	States	is	projected	to	increase	dramatically	with	an	increasingly	aging	population.	The	chief	medical	intervention	for	patients	with	cataracts	is	to	surgically	remove	the	cloudy	lens	through	an	incision	made	in	the	cornea,	while	leaving	the	fibrous	lens	capsule	that	contained	the	lens	cells	intact.	An	artificial	lens	is	then	inserted	into	the	lens	capsule.	The	new	artificial	lens	does	not	attach	to	the	suspensory	ligaments	of	the	existing	ciliary	muscles	and	is	therefore	incapable	of	“accommodation”—the	subtle	adjustments	of	lens	shape	that	allow	the	eye	to	focus	at	different	focal	lengths—but	it	nonetheless	mostly	restores	useful	vision	to	patients,	and	has	been	successfully	used	for	many	decades	(Asbell	et	al.,	2005;	Harper	and	Shock,	2011).	Congenital	aphakia	(absence	of	a	lens)	can	affect	children	born	with	genetic	mutations	affecting	eye	development,	or	those	affected	by	rubella	infection	in	utero.	Intraocular	lens	implantation	in	such	children	frequently	leads	to	adverse	effects	that	warrant	further	surgery	(Group,	2010,	2014).	There	is	thus	a	pressing	need	for	non-surgical	alternatives	for	pediatric	patients	with	aphakia.		 Although	the	current	treatment	for	cataracts	works	well,	it	has	been	delivered	in	the	absence	of	a	clear	model	of	the	pathogenesis	of	the	disease.	Despite	its	ostensibly	simple	appearance,	the	lens	is	a	complex	structure	whose	specialized	fiber	cells	rich	with	crystallin	proteins	are	de-nucleated,	elongated,	and	laid	out	in	a	highly	regular	concentric	pattern	during	embryogenesis,	making	the	structure	completely	transparent	to	visible	light.	The	various	molecular	and	cytological	changes	that	occur	to	lose	this	transparency	over	time	are	largely	unknown,	and	our	present	understanding	is	so	limited	that	there	is	little	hope	of	preventing	or	
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reversing	this	effect.	Due	to	this	lack	of	understanding,	it	cannot	be	asserted	with	confidence	that	the	increasingly	large	amount	of	resources	spent	on	cataract	surgeries	and	artificial	lens	implantations	represent	the	best	possible	solution	to	an	ever-expanding	public	health	issue.	A	deep	understanding	of	the	genesis	of	a	proper	lens	can	allow	us	to	develop	therapies	to	slow,	halt,	or	reverse	the	corruption	of	a	lens.	Studying	vertebrate	lens	regeneration	affords	us	the	opportunity	to	do	this	as	we	can	observe	(and	intervene	at)	various	stages	of	generating	a	lens	de	novo.			It	should	be	noted	that	even	once	we	acquire	a	complete	understanding	of	how	to	trigger	the	formation	of	a	new	lens	in	patients	with	cataracts,	the	removal	of	the	existing	opaque	lens	would	still	be	necessary,	and	thus	surgery	would	still	be	needed.	A	newly	regenerated	lens	may	not	even	properly	attached	to	ciliary	muscles	to	enable	proper	focusing	of	the	lens.	Thus,	it	is	not	likely	that	the	findings	from	our	field	of	research	will	directly	lead	to	a	therapy	that	will	one	day	usurp	the	current	treatment	of	lens	removal	and	artificial	lens	implantation.	Instead,	we	can	lay	down	the	foundation	from	which	future	work	can	build	clinical	interventions	that	are	rooted	in	knowledge	of	how	a	transparent	lens	is	generated,	ensuring	in	our	future	both	the	best	quality	of	outcome	possible	for	patients,	and	the	best	use	of	limited	healthcare	resources.			
1.2	Xenopus	lens	regeneration	is	biologically	interesting			 A	fundamental	question	in	biology	is	why	some	animals	are	capable	of	regenerating	certain	tissues	and	others	are	not.	Addressing	this	question	is	the	key	to	endowing	our	own	tissues,	normally	incapable	of	regeneration,	with	the	capacity	to	self-renew	or	regenerate	following	disease,	damage,	or	loss.	Lens	regeneration	is	a	relatively	uncommon	phenomenon	amongst	vertebrates,	and	besides	species	of	the	frog	genus	Xenopus,	it	has	been	observed	in	some	salamanders	and	one	fish.	No	mammals	are	known	to	have	the	ability	to	naturally	regenerate	the	intact	lens.			
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Although	there	are	clear	advantages	to	being	able	to	regenerate	lost	organs	like	the	lens,	it	is	unclear	what	selective	pressures	would	have	directed	the	evolution	of	this	particular	phenomenon	in	Xenopus.	There	exists	a	possibility	that	lens	regeneration	in	this	animal	is	not	the	product	of	selective	pressures	to	specifically	regenerate	this	tissue,	but	is	rather	an	emergent	property	of	the	relevant	tissues	resulting	from	the	way	Xenopus	develops	the	lens	during	embryogenesis.		The	process	of	lens	regeneration	from	the	cornea	is	remarkably	similar	to	the	process	of	embryonic	lens	development	(see	section	1.4).	The	cornea	epithelium	from	which	the	regenerated	lens	is	derived	originates	from	the	same	head	ectoderm	that	the	original	lens	is	derived	from.	In	both	regeneration	and	development,	molecular	signals	from	the	neural	retina	reach	the	overlying	ectoderm	and	trigger	it	to	differentiate	into	a	lens.	The	capacity	of	the	cornea	to	respond	to	these	retinal	signals	remains	throughout	larval,	juvenile	stages,	and	even	adult	stages;	thus	the	inducing	nature	of	the	eyecup,	and	the	lentogenic	nature	of	the	cornea	ectoderm	are	carried	over	from	embryogenesis.	Under	this	view,	lens	regeneration	in	Xenopus	may	simply	be	a	coincidental	by-product	of	the	animal’s	developmental	scheme,	rather	than	being	an	adaptive	result	of	Darwinian	selection.	So	long	as	the	nature	of	ocular	development	in	the	animal	is	such	that	the	relevant	tissues	can	recapitulate	their	roles	from	development,	they	will	remain	capable	of	contributing	to	regeneration	in	post-embryonic	stages.	In	other	words,	the	regeneration	phenotype	need	only	be	as	evolutionarily	stable	as	the	manner	of	embryonic	organogenesis	itself,	and	thus	the	ability	to	regenerate	lenses	will	remain	in	the	population	despite	the	absence	of	selective	pressures	that	specifically	favor	it.	The	phenomenon	then	is	absent	in	mammals	because	their	developing	corneas	lose	their	natural	lentogenicity	more	soon	in	the	course	of	eye	development.		 	On	the	other	hand,	newts	and	cobitid	fish	that	can	regenerate	lenses	from	the	iris	(termed	“Wolffian	regeneration”)	have	natural	ocular	parasites	that	can	damage	the	lens	and	render	the	animal	blind	in	that	eye,	providing	an	obvious	selective	pressure	driving	the	evolution	of	lens	regeneration	(Henry,	2003).	Although	many	parasites	are	known	to	infect	Xenopus,	none	are	reported	to	specifically	infect	the	
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eye.	This	could	be	because	the	parasite	went	extinct	suddenly	and	recently,	perhaps	due	to	some	human-influenced	environmental	changes	in	the	African	region	to	which	the	frog	and	parasite	are	native.	If	so,	the	ability	to	regenerate	the	lens	is	merely	a	vestige	to	the	animal,	and	a	scientific	opportunity	to	us.	Much	of	what	is	known	about	parasites	in	Xenopus	is	reported	from	Californian	populations	rather	than	from	Africa	where	the	animal	evolved	(Kuperman	et	al.,	2004),	so	it	may	be	that	we	have	simply	not	yet	discovered	a	parasite	or	agent	that	drove	the	evolution	of	lens	regeneration	in	Xenopus.	Many	mammals	including	humans	harbor	a	wide	variety	of	ocular	parasites	(Otranto	and	Eberhard,	2011),	and	some	parasites	are	able	to	infest	and	damage	the	mammalian	lens	(Lester	and	Freeman,	1976).	In	light	of	this	it	is	conceivable	that	we	will	one	day	discover	that	the	ability	to	naturally	regenerate	a	lens	extends	into	the	mammalian	class	as	well,	given	that	they	may	share	this	selection	pressure	in	common	with	urodeles	(newts).	While	no	individual	experiment	described	in	these	pages	was	set	up	with	the	express	purpose	of	probing	evolutionary	history,	our	work	as	a	whole	nonetheless	sheds	light	on	species-specific	differences	in	lens	regeneration,	and	by	obtaining	a	more	comprehensive	description	of	what	transpires	during	regeneration,	one	can	formulate	better	hypotheses	aimed	at	understanding	the	origins	and	causes	of	such	regenerative	phenomena.			
1.3	The	history	and	present	status	of	Xenopus	as	a	model	for	lens	regeneration			 Lens	regeneration	can	be	easily	initiated	in	Xenopus	under	defined	experimental	conditions.	It	begins	with	the	removal	of	the	lens	from	the	eye—termed	“lentectomy”	in	our	field,	although	it	is	also	commonly	called	“lensectomy”	in	human	medicine.	In	doing	so,	the	inner	cornea	epithelium	that	overlies	the	pupillary	aperture	is	torn,	and	molecular	factors	secreted	by	the	neural	retina	are	free	to	reach	the	outer	cornea	epithelium	(Fig.	1.1).	The	original	work	by	Freeman	(Freeman,	1963)	that	characterized	Xenopus	lens	regeneration	divided	the	subsequent	histological	events	into	5	distinct	stages.	In	stage	1,	the	cells	of	the	innermost	visible	layer	of	the	cornea	epithelium	change	from	squamous	to	cuboidal	
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in	appearance.	This	change	is	observed	even	when	the	cornea	is	merely	wounded	without	a	lentectomy.	In	stage	2,	basal	cells	that	lie	directly	over	the	pupillary	aperture	undergo	aggregation	to	form	a	loose	clump	of	cells	that	are	2-3	layers	thick.	In	stage	3,	those	cells	become	reoriented	toward	each	other	and	begin	to	separate	from	the	other	inner	cells	of	the	outer	cornea	epithelium,	forming	a	vesicle-like	structure.	In	stage	4,	the	vesicle	has	enlarged,	as	have	the	nuclei	of	many	of	the	cells.	These	cells	produce	few	irregular	lens	fibers,	and	the	cells	of	the	vesicle	synthesize	lens	proteins	called	“crystallins”.	Often	but	not	always,	the	vesicle	may	be	entirely	detached	from	the	cornea.	In	stage	5,	lens	fiber	cells	have	formed	and	more	emerge	from	the	equatorial	zone	of	the	lens	epithelium.	Fiber	cell	nuclei	begin	to	disappear,	and	the	lens	continues	to	grow	in	size.	This	study	also	demonstrated	that	the	origin	of	the	regenerated	lens	is	truly	from	corneal	epithelial	cells	by	labeling	the	cornea	with	thymidine,	and	observing	the	presence	of	the	labeled	cells	in	the	newly	regenerated	lens	(Freeman,	1963).	Henry	and	Elkins	also	showed	that	when	GFP-labeled	corneas	from	transgenic	larvae	of	X.	tropicalis	were	transplanted	into	wild-type	eyecups,	the	regenerated	lens	would	also	be	GFP	positive,	demonstrating	the	corneal	origins	of	the	new	lens	(Henry	and	Elkins,	2001).	The	process	of	the	cornea	transforming	and	giving	rise	to	a	lens	has	historically	been	described	as	“cornea-lens	transdifferentiation”	(Cannata	et	al.,	2008;	Day	and	Beck,	2011;	Henry,	2003;	Henry	and	Elkins,	2001;	Henry	and	Tsonis,	2010b;	Schaefer	et	al.,	1999),	implying	some	form	of	metaplasia	must	be	occurring	to	transform	corneal	cells	into	lens.	Recent	work	has	challenged	this	idea	however,	suggesting	that	a	population	of	oligopotent	cornea	stem	cells	might	be	the	source	of	the	regenerated	lens	(Perry	et	al.,	2013).				 Various	studies	have	shown	that	the	presence	of	the	lens	and	inner	cornea	act	as	barriers	that	block	neural	factors	that	trigger	lens	regeneration	from	reaching	the	outer	cornea.	Under	normal	circumstances,	in	the	absence	of	any	injury	to	the	lens	or	inner	cornea,	these	barriers	prevent	spontaneous	lens	regeneration	events	from	the	outer	cornea.	Corneal	explants	placed	into	the	eye	cup	will	form	new	lenses	even	in	the	presence	of	the	existing	lens,	showing	that	the	lens	does	not	secrete	
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inhibitory	factors	to	halt	regeneration	(Bosco	et	al.,	1980).	Even	when	small	barriers	like	cutouts	of	Millipore	filters	are	placed	into	the	vitreous	chamber	of	a	lentectomized	eye,	in	between	the	outer	cornea	and	neural	retina,	lens	regeneration	is	prevented	by	their	obstructive	presence	(Cioni	et	al.,	1982;	Filoni	et	al.,	1981).	Additionally,	if	the	lens	is	removed	through	an	incision	in	the	posterior	aspect	of	the	eye	without	puncturing	the	inner	cornea,	then	regeneration	will	not	commence	if	the	inner	cornea	is	still	intact	(Bosco	et	al.,	1979).	Taken	together,	it	is	clear	that	these	structures	act	as	mechanical	barriers	that	physically	block	the	diffusion	of	retinal	signals,	and	not	as	tissues	that	release	paracrine	signals	that	inhibit	regeneration.			 These	findings	must	be	reconciled	with	the	observation	that	although	a	sheet	of	lens-competent	cornea	epithelium	is	wholly	exposed	to	retinal	signals	following	lentectomy,	only	one	new	lens	is	typically	regenerated;	regeneration	does	not	occur	at	multiple	foci	in	the	cornea	resulting	in	multiple	lenses.	This	observation	is	most	simply	explained	by	the	existence	of	some	secreted	factor	released	in	the	early	stages	of	regeneration	that	suppresses	the	regeneration	of	more	than	one	lens.	Freeman	stage	1	can	be	initiated	with	corneal	damage	alone	and	without	lentectomy	(Freeman,	1963),	so	it	is	unlikely	that	the	suppressive	signal	would	emerge	during	a	stage	that	is	neither	unique	to,	nor	a	definitive	predictor	of	lens	regeneration.	A	paracrine	signal	released	by	the	nascent	lentoid	vesicle	that	forms	during	Freeman	stage	2	of	regeneration	could	suppress	the	formation	of	new	vesicles,	while	permitting	the	growth	of	the	existing	one.	However,	no	published	studies	have	yet	demonstrated	this	possibility	explicitly.		 The	rate	at	which	the	inner	cornea	heals	back	following	lentectomy	is	the	greatest	factor	that	limits	the	tadpole’s	ability	to	naturally	regenerate	a	lens	as	it	matures	into	late	larval	stages.	Tadpoles	approaching	metamorphosis	have	reduced	success	in	regenerating	the	lens,	which	progressively	worsens	as	the	animal	grows	(Freeman,	1963).	However,	if	pieces	of	cornea	are	inserted	into	the	vitreous	chamber	of	these	relatively	mature	tadpoles,	they	can	form	new	lenses	efficiently,	
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demonstrating	that	the	effect	is	neither	due	to	a	loss	of	lens-regenerating	competence	of	the	cornea,	nor	a	loss	of	lens-inducting	capability	of	the	retina	(Filoni	et	al.,	1997).	Moreover,	Xenopus	tropicalis	rarely,	and	Xenopus	borealis	never	regenerate	lenses	naturally	following	a	simple	lentectomy	because	their	inner	corneas	heal	too	quickly	and	block	the	influence	of	retinal	signals.	Strikingly,	if	corneas	are	placed	into	the	vitreous	chamber	however,	both	of	these	animals	can	efficiently	form	new	lenses	(Filoni	et	al.,	2006;	Henry	and	Elkins,	2001),	further	demonstrating	the	occlusive	role	of	the	inner	cornea.			 The	necessity	of	the	eyecup	for	lens	regeneration	was	demonstrated	early	on,	when	it	was	observed	that	the	cornea	would	not	form	a	lens	if	the	eye	was	completely	removed	behind	it	(Freeman,	1963).	Although	it	was	unclear	at	the	time	what	inductive	signals	the	eyecup	released,	a	large	body	of	work	has	since	emerged	regarding	the	role	of	the	neural	retina	and	ligands	that	it	secretes	that	leads	to	lens	regeneration.	For	instance,	many	studies	have	demonstrated	that	a	lens	can	regenerate	when	cornea	is	implanted	into	the	vitreous	chamber	(Bosco	et	al.,	1993a;	Bosco	et	al.,	1993b;	Bosco	et	al.,	1992;	Filoni	et	al.,	1997;	Filoni	et	al.,	1981;	Henry	and	Elkins,	2001;	Reeve	and	Wild,	1978).	The	vitreous	chamber	is	the	spherical	inner	space	of	the	eye	bound	by	the	lens	and	inner	cornea-covered	pupillary	opening	anteriorly,	and	by	the	neural	retina	posteriorly.	In	mammals	it	contains	the	“vitreous	humour”—a	gelatinous	mass	that	maintains	the	inner	pressure	of	the	eye	(Ross	and	Pawlina,	2011).	Being	in	immediate	contact	with	the	neural	retina,	it	presumably	harbors	any	secretions	from	the	cells.	Taken	together	with	the	finding	that	that	corneas	exposed	to	denatured	eyecups,	whole	retinal	protein	extracts,	or	retina-conditioned	culture	media	will	also	form	lenses	(Filoni	et	al.,	1983),	it	appears	that	the	signals	of	the	retina	are	necessary	and	sufficient	to	trigger	lens	regeneration.	While	it	is	not	entirely	clear	whether	a	single	molecule	or	a	multitude	of	signals	triggers	regeneration	in	vivo,	the	Fibroblast	Growth	Factor	(FGF)	pathway	is	known	to	be	important.	Not	only	is	FGF	signaling	necessary	for	lens	regeneration	to	occur	(Fukui	and	Henry,	2011),	but	the	addition	of	FGF-1	has	been	shown	to	be	
  9 
sufficient	to	trigger	lens	formation	from	isolated	corneas	in	vitro	(Bosco	et	al.,	1994,	1997;	Moore,	2015).				 Several	species	of	salamanders,	as	well	as	the	cobitid	fish,	and	chick	embryos,	are	also	capable	of	regenerating	lost	lenses	(reviewed	by	(Henry,	2003;	Henry	et	al.,	2013;	Henry	and	Tsonis,	2010a;	Tsonis	et	al.,	2004)).	They	do	so	through	a	process	known	as	“Wolffian	regeneration”,	wherein	cells	of	the	pigmented	iris	become	de-pigmented,	and	then	proliferate	to	form	a	lens	vesicle	that	grows	into	a	new	lens.	Studies	from	these	species	have	synergistically	advanced	our	understanding	of	the	regenerative	biology	of	the	lens.				 X.	laevis	offers	many	advantages	over	other	models	to	study	vertebrate	lens	regeneration.	The	adult	animals	are	readily	reared	in	relatively	simple	aquaria	following	straightforward	and	well-established	protocols	(Henry	et	al.,	2008;	Nieuwkoop,	1956).	They	are	poikilothermic	animals	that	tolerate	a	wide	range	of	temperatures.	In	the	rearing	conditions	of	our	own	lab,	the	larvae	for	experiments	are	produced	in	large	numbers,	and	reach	stage	48	(the	earliest	stage	we	perform	lens	regeneration	studies)	within	3-4	weeks,	and	they	develop	to	suitable	larval	stages	(stages	48-54)	for	another	3-4	weeks	before	undergoing	metamorphosis	(unpublished	observations).	In	vivo	experiments	require	nothing	more	than	an	inexpensive	buffered	solution	(Normal	Amphibian	Media,	NAM),	or	de-chlorinated	tap	water.	Even	their	cornea-derived	cell	lines	thrive	under	ambient	temperature	and	gases.	The	larvae	tolerate	surgical	procedures	and	prolonged	anesthesia	extremely	well	(Hamilton	and	Henry,	2014).	Importantly,	the	larvae	are	small	enough	to	carry	out	experiments	in	large	numbers,	but	big	enough	that	delicate	surgical	procedures	can	be	performed	by	human	hands	using	very	simple	and	widely	available	tools.		 One	of	the	most	important	experimental	designs	we	implement	to	study	lens	regeneration	is	the	use	of	an	ex	vivo	eye	culture	system	(which	we	have	in	the	past	called	an	“in	vitro	eye	culture	system”	(Fukui	and	Henry,	2011;	Thomas	and	Henry,	
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2014)).	In	this	system,	the	cornea	can	be	implanted	into	the	vitreous	chamber,	while	the	eye	is	excised	and	cultured	in	small	volumes	of	culture	media.	This	allows	the	use	of	pharmacological	inhibitors	that	might	normally	be	toxic	to	intact	live	animals,	or	too	expensive	to	use	in	large	volumes.	Under	these	conditions	the	effects	of	the	molecules	are	also	limited	to	the	ocular	tissues,	limiting	pleiotropic	effects	caused	by	systemic	exposure.	The	whole-eye	explants	regenerate	lenses	within	5-7	days	and	can	be	examined	with	standard	histology	and	immunohistochemical	protocols.	Alternatively,	ocular	tissues	can	be	isolated	for	obtaining	DNA,	RNA,	or	protein.	The	media	used	in	ex	vivo	cultures	is	nothing	more	than	antibiotic	and	serum-supplemented	L-15	media	that	has	been	diluted	3:4.	We	have	also	found	that	
Xenopus	cell	lines	also	prefer	this	lower	osmolarity	media	(unpublished	observations).	One	limitation	of	this	system	however	is	that	the	explanted	eye	often	does	not	retain	its	shape	as	robustly	as	an	eye	that	is	present	in	the	head	of	an	animal	that	has	been	fixed.	The	eye	often	deforms	in	the	course	of	fixation,	histological	preparation,	and	sectioning.			
1.4	Embryonic	development	of	the	lens	and	cornea			 In	the	early	20th	century,	the	experimental	embryologist	Hans	Spemann	published	a	seminal	body	of	work	establishing	the	concept	of	embryonic	induction	in	the	development	of	the	amphibian	nervous	system.	His	groundbreaking	paper	from	1924	regarding	embryonic	grafts	introduced	the	idea	of	the	Spemann-Mangold	organizer	and	that	cell-to-cell	induction	events	led	to	the	differentiation	of	cells	and	their	neighbors,	a	critical	paradigm	that	guided	decades	of	developmental	biology	that	followed	(De	Robertis,	2006;	Spemann	and	Mangold,	1924).	Although	this	Nobel	Prize-winning	work	is	widely	known	amongst	modern	biologists	for	introducing	the	concept	of	tissue	induction,	Spemann’s	characterization	of	induction	began	much	earlier,	with	his	experiments	on	frog	eye	development.	In	1901,	he	observed	that	the	unilateral	ablation	of	the	presumptive	eye	rudiment	led	to	a	failure	of	lens	development	on	that	side	(Saha,	1991;	Spemann,	1901),	and	although	it	was	not	obvious	at	the	time,	it	was	one	of	the	first	demonstrations	of	the	
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importance	of	induction	during	embryogenesis.	This	work	and	much	of	his	work	leading	up	to	the	characterization	of	the	Spemann-Mangold	organizer	over	20	years	later	was,	by	Spemann’s	own	account,	inspired	by	the	work	of	his	academic	contemporary	and	close	friend	Gustav	Wolff—the	namesake	of	“Wolffian	regeneration”	who	characterized	amphibian	lens	regeneration	from	the	iris	(Saha,	1991).	The	histories	of	the	fields	of	lens	regeneration	and	eye	development	are	thus	closely	tied	together.			 Embryonic	tissue	is	fated	for	eye	contribution	well	before	actual	morphogenesis	of	the	eye.	Eye	development	begins	as	early	as	the	formation	of	the	neural	plate.	Before	it	invaginates	in	the	process	of	neurulation,	a	subsection	of	the	neural	plate	specializes	into	the	‘eye	field’	under	the	direction	of	various	signaling	pathways	including	BMP,	FGF,	and	Wnt.	In	Xenopus,	the	eye	field	is	defined	by	the	expression	patterns	of	various	transcription	factors:	Otx2,	Six3,	Rax,	Tbx3,	Lhx2,	Tll,	
Six6,	and	Pax6,	collectively	known	as	Eye	Field	Transcription	Factors	(EFTFs)	(reviewed	by	Graw,	2010).	Later,	the	eye	field	separates	into	two	bilateral	‘eye	primordia’	upon	the	influence	of	sonic	hedgehog	(Shh)	signaling,	and	occurs	in	concert	with	the	establishment	of	the	midline	(Chiang	et	al.,	1996;	Li	et	al.,	1997).	Each	of	the	twin	eye	primordia	then	begin	to	invaginate	to	form	the	‘optic	pits’.	Mutual	inductive	signaling	interactions	occur	between	the	optic	pit	and	the	ectoderm	that	overlies	it.	This	signaling	has	the	effect	of	further	invagination	until	it	becomes	the	‘optic	vesicle’.	A	wall	of	ectodermal	tissue	wraps	around	this	pit	as	the	pit	deepens,	coming	in	from	two	sides	and	eventually	meeting	and	fusing	like	a	zipper.	As	these	walls	have	formed	around	the	pit,	the	optic	vesicle	has	achieved	the	familiar	spheroid	shape	of	the	eyecup.	The	ventral	seam	at	the	site	of	new	ectodermal	tissue	fusion	is	known	as	the	‘choroid	fissure’	and	is	invisible	in	human	eyes,	but	can	be	seen	as	a	pigmented	raphe	in	many	animals,	including	Xenopus.	The	optic	vesicle	has	by	now	also	been	elevated	away	from	surrounding	ectoderm	(fated	to	be	brain).	The	narrow	pillar	that	connects	the	optic	vesicle	to	the	surrounding	ectoderm	is	called	the	‘optic	stalk’,	and	it	will	eventually	become	the	‘optic	nerve’,	
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through	which	all	visual	information	is	transmitted	to	the	brain	(Graw,	2010;	Paulsen,	2010).	The	surface	ectoderm	overlying	the	opening	of	the	optic	vesicle	thickens	to	form	the	‘lens	placode’.	The	formation	of	the	lens	placode	is	often	considered	the	first	step	in	lens	development,	but	specification	of	the	lens	placode	begins	even	earlier	than	optic	vesicle	formation	in	Xenopus,	as	signals	from	the	anterior	neural	plate	and	underlying	tissues	act	as	early	lens	inductors	(Henry	and	Grainger,	1990).	Soon,	the	optic	vesicle	invaginates	and	enlarges	further	to	become	the	‘optic	cup’.	At	the	same	time,	the	lens	placode	over	it	undergoes	a	reciprocal	process	and	has	invaginated	to	form	a	‘lens	cup’,	and	later	a	‘lens	vesicle’.	Note	that	Freeman	stages	1-3	of	lens	regeneration	are	histologically	reminiscent	of	lens	vesicle	development	until	this	point,	insofar	as	retinal	inductive	signals	lead	to	the	thickening	and	vesicularization	of	overlying	ectoderm.	The	lens	vesicle	has	by	now	also	evaginated	into	the	optic	cup,	and	once	it	detaches	from	the	surface	ectoderm,	it	is	known	simply	as	the	‘lens’.	The	region	of	surface	ectoderm	from	where	the	lens	budded	off	will	eventually	become	the	cornea	epithelium,	and	the	inner	cells	of	the	optic	cup	will	give	rise	to	the	neural	retina	(Graw,	2010).				 The	development	of	the	lens	and	cornea	until	this	stage	has	been	a	model	example	of	inductive	signaling	during	embryogenesis,	and	a	large	amount	of	our	understanding	of	this	process	came	from	studying	Xenopus	and	other	amphibians.	Not	long	after	Spemann’s	original	eye	rudiment	ablation	experiments,	Lewis	showed	that	ectopic	implantation	of	the	optic	vesicle	underneath	head	ectoderm	that	was	not	fated	for	lens	formation	can	trigger	that	ectoderm	to	form	a	lens	(Lewis,	1904).	An	expansive	body	of	work	soon	emerged	in	the	early	and	mid	20th	century,	variously	confirming	and	challenging	the	sufficiency	of	the	optic	vesicle	to	induce	the	formation	of	a	lens	(reviewed	by	Saha	et	al.,	1989).	Eventually,	work	performed	with	rigorous	controls	and	proper	host-	and	donor-marking	systems	would	essentially	confirm	Lewis’s	findings	that	the	optic	vesicle	can	by	itself	induce	lens	formation	in	non-lens	fated	ectoderm	(Liedke,	1955;	Reyer,	1958).	However,	this	finding	should	be	understood	with	the	important	caveat	that	a	subset	of	non	lens-
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fated	ectoderm	is	still	nonetheless	lens-biased,	owing	to	separate	inductive	events	that	occur	as	early	as	gastrulation,	and	it	is	only	upon	such	lens-biased	ectoderm	that	the	optic	cup	can	exert	its	lentogenic	influence	(Grainger	et	al.,	1988;	Henry	and	Grainger,	1987,	1990).	The	mature	eyecup	of	Xenopus	larvae	can	strongly	induce	lens	formation	from	isolated	embryonic	presumptive	lens	ectoderm,	suggesting	that	the	inductive	signals	are	likely	the	same	in	both	lens	development	and	regeneration	(Henry	and	Mittleman,	1995).	Moreover,	the	eyecup	weakly	induces	lenses	from	ventral	ectoderm	that	cannot	be	induced	by	the	optic	cup,	suggesting	that	the	signaling	from	the	eyecup	(such	as	what	occurs	during	lens	regeneration)	is	more	intense	than	that	of	the	embryonic	optic	cup	(Henry	and	Mittleman,	1995).	Still,	the	eyecup	cannot	induce	lenses	from	larval	ventral	flank	ectoderm	(Henry	and	Elkins,	2001),	showing	that	some	kind	of	lentogenic	bias	(or	“lens	competence”)	is	still	required	for	lens	regeneration,	just	as	it	is	for	lens	development.	Our	understanding	of	lens	regeneration	has	thus	grown	concurrently	with	our	growing	understanding	of	lens	induction,	and	it	is	clear	that	the	inductive	paradigm	is	very	similar	in	both	development	and	regeneration.				 Following	closure	of	the	lens	cup	into	a	lens	vesicle,	the	interior	is	left	with	a	central	cavity.	Lens	epithelial	cells	line	the	anterior	face	of	the	now	spheroid	structure	with	their	basement	membrane	lying	superficial	to	the	cells	themselves.	Other	cells	from	both	the	anterior	and	posterior	pole	begin	to	elongate	until	they	meet	each	other	end-to-end	towards	the	center	of	the	sphere	and	fill	up	the	cavity.	These	elongated	cells	are	called	‘primary	lens	fiber	cells’.	Mitotic	cells	from	the	lens	epithelium	then	divide	and	migrate	towards	the	equator	of	the	lens,	and	upon	reaching	there	they	begin	to	differentiate	and	elongate.	As	newer	cells	arrive	at	the	equator,	older	ones	get	pushed	centrally	and	elongation	continues.	These	new	epithelium-derived	elongated	cells	are	called	‘secondary	lens	fiber	cells’.	As	the	tips	of	elongated	secondary	fiber	cells	from	opposite	poles	of	the	equator	begin	to	meet	at	the	midline,	their	fused	ends	form	anterior	and	posterior	sutures.	In	a	transverse	section	of	the	lens,	the	cells	now	appear	as	concentric	circles.	As	primary	and	secondary	fiber	cells	near	the	center	of	the	lens,	they	also	begin	to	lose	their	nuclei	
  14 
and	other	organelles.	Fiber	cells	always	elongate	along	the	anterior-posterior	axis,	and	new	cells	always	come	in	only	from	the	equator.	This	assures	that	a	uniform	fiber	cell	polarity	is	always	achieved,	forming	an	organized	latticework	of	cells	within	the	lens	that	is	critical	for	maintaining	transparency	and	optical	quality.	Lens	maturation	in	this	manner	continues	after	birth,	and	even	primary	fiber	cells	do	not	become	fully	denucleated	until	2	weeks	after	opening	of	the	eyelids.	Fiber	cell	elongation	and	the	maintenance	of	lens	polarity	(with	the	lens	epithelium	facing	the	anterior	only)	are	the	result	of	sustained	signaling	from	the	neural	retina,	even	in	adult	animals	(Coulombre	and	Coulombre,	1963;	Yamamoto,	1976).	The	basement	membrane	surrounding	the	lens	vesicle	thickens	to	form	the	fibrous	lens	capsule.	Fiber	cells	are	never	shed	from	the	lens	(Fig	1.2).	Even	the	original	primary	fiber	cells	from	embryogenesis	are	retained	in	the	metabolically	quiescent	core	of	the	lens	for	life,	entombed	within	the	fibrous	lens	capsule	and	many	layers	of	younger	cells,	and	isolated	from	humoral	elements	(lens	development	reviewed	by	(Graw,	2010;	McAvoy	et	al.,	1999;	Rao,	2008)).		Lens	regeneration	essentially	recapitulates	lens	development	and	maturation	perfectly	during	Freeman	stages	3-5,	until	it	culminates	in	a	lens	that	is	indistinguishable	from	its	lens	placode-derived	counterpart	(Freeman,	1963).	The	chief	component	of	the	terminally	differentiated	fiber	cells	is	a	group	of	proteins	known	as	“crystallins”	(which	constitute	a	third	of	the	total	cellular	mass),	the	major	ones	of	which	are	α-,	β-,	and	γ-crystallin	(Graw,	2009).	Crystallins	are	key	molecular	markers	that	identify	differentiated	lens	cells,	and	antibodies	that	stain	for	lens	proteins	have	been	instrumental	for	positive	identification	of	lenses	of	varying	stages	during	development	and	regeneration.	As	mentioned,	the	ex	vivo	eye	culture	system	we	use	can	often	fail	to	preserve	the	structure	of	the	lens,	and	lens	cells	can	look	very	similar	to	other	nearby	epithelial	cells,	depending	on	the	stage	of	differentiation.	Thus,	the	creation	of	a	polyclonal	antibody	that	broadly	stains	for	
Xenopus	crystallins	(Henry	and	Grainger,	1987)	has	been	a	critical	tool	that	enables	our	use	of	the	ex	vivo	culture	system.					
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	 As	mentioned	above,	the	ectoderm	that	overlies	the	lens	vesicle	eventually	gives	rise	to	the	cornea	epithelium.	As	the	lens	vesicle	separates	from	surface	ectoderm,	cells	of	neural	crest	origin	invade	the	resulting	space	between	them.	In	mammals,	this	results	in	several	layers	of	cells	between	the	cornea	epithelium	and	the	lens.	They	later	form	a	loose	arrangement	of	cells	with	a	lot	of	extracellular	matrix,	known	as	the	corneal	stroma.	The	posterior	layer	of	the	cells	(derived	from	the	neural	crest)	that	lies	closest	to	the	lens	remains	as	a	tight	sheet	and	is	called	the	lens	endothelium	(Graw,	2010).	Xenopus	varies	from	other	vertebrates	at	this	stage	because	of	anatomical	differences	of	the	pre-metamorphic	larval	eye.	In	tadpoles,	the	cornea	epithelium	has	no	stroma	formation	under	it	and	is	usually	called	the	“outer	cornea”	(or	“outer	cornea	epithelium”	or	simply	“cornea	epithelium”).	The	cornea	endothelium	remains	separated	from	the	epithelium	except	at	the	center.	Another	wave	of	migrated	neural	crest	cell	joins	the	cornea	endothelium	to	form	an	“inner	cornea”	which	lies	over	the	pupillary	opening,	and	while	it	is	directly	connected	to	the	outer	cornea	via	a	small	corneal	stalk,	it	remains	otherwise	separate	from	it.	As	the	animal	undergoes	metamorphosis,	keratinocytes	are	drawn	towards	the	corneal	stalk	and	a	stroma	is	deposited,	and	the	cornea	thickens	until	the	tissue	soon	resembles	a	human	cornea	(Hu	et	al.,	2013).		
1.5	An	overview	of	the	Retinoic	Acid	signaling	pathway	members1	
	 Retinol	(Vitamin	A)	is	the	biological	source	of	retinoids	in	animals,	which	binds	to	Retinol	Binding	Protein	(RBP4)	in	the	blood	before	being	delivered	to	the	transmembrane	protein	on	the	surface	cells,	Stimulated	by	retinoic	acid	(STRA6).	In	the	cytosol,	retinol	is	bound	to	cytoplasmic	retinol	binding	protein	(CRBP1),	and	is	oxidized	to	retinaldehyde	by	a	suite	of	dehydrogenases	such	as	RDH10,	and	is	subsequently	oxidized	to	retinoic	acid	by	tissue-specific	retinaldehyde	dehydrogenases	RALDH1/2/3	(Molotkov	et	al.,	2002a;	Molotkov	et	al.,	2002b).	RA	is	
                                                
1 Some of the content of this section is excerpted from: Henry, J.J., Thomas, A.G., Hamilton, P.W., Moore, 
L., Perry, K.J., 2013. Cell signaling pathways in vertebrate lens regeneration. Curr Top Microbiol Immunol 
367, 75-98. All excerpted content was authored solely by Alvin G Thomas. 
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bound	by	cellular	retinoic	acid	binding	protein	(CRABP)	and	transported	to	the	nucleus	where	it	is	released.	RA	exerts	its	influence	on	the	cell	by	binding	to	Retinoic	Acid	Receptors	(RARα/β/γ)	and	Retinoid	X	Receptors	(RXRα/β/γ),	which	dimerize	and	bind	to	specific	genomic	elements	known	as	retinoic	acid	response	elements	(RAREs),	where	they	act	as	transcriptional	activators	or	repressors.	In	the	absence	of	ligand,	the	aporeceptors	generally	act	to	recruit	chromatin	condensing	histone	deacetylases,	and	when	RA	is	bound	to	the	receptors	the	chromatin	is	remodeled	to	enable	transcription,	via	the	recruitment	of	histone	acetyl	transferases	(Niederreither	and	Dolle,	2008).	RA	may	also	form	a	complex	with	CRABP	and	exit	the	cell,	enabling	RA	signaling	to	act	in	both	autocrine	and	paracrine	fashions	(Cvekl	and	Wang,	2009).			 There	is	also	a	cytochrome	P450	superfamily	enzyme	known	as	CYP26,	which	metabolizes	retinoic	acid	into	polar	metabolites	such	as	4-oxo-retinoic	acid	in	order	to	be	eliminated	from	the	cell.	Several	early	studies	using	radiolabelled	RA	had	revealed	that	RA	formed	various	metabolic	products	that	were	excreted	in	animal	urine,	and	that	their	formation	was	NADPH	dependent	(reviewed	by	(Ross	and	Zolfaghari,	2011)),	suggesting	the	existence	of	a	heme-containing	cytochrome	P450-like	monooxygenase	for	degrading	RA	in	vivo.	The	responsible	enzyme	however	was	not	identified	and	characterized	until	1996	and	was	called	P450RAI	at	the	time	(White	et	al.,	1996).	It	would	later	be	named	CYP26,	and	it	was	cloned	and	characterized	in	Xenopus	soon	after	(Hollemann	et	al.,	1998).	As	is	typical	for	hepatic	cytochrome	P450s,	there	are	multiple	enzymes	that	can	act	upon	RA	with	varying	degrees	of	affinity	in	liver	cells.	However,	CYP26	has	the	highest	affinity	for	RA,	and	it	is	the	principal	P450	enzyme	involved	in	attenuating	RA	signaling	in	cells	and	tissues	(Ross	and	Zolfaghari,	2011).	The	coordinated	expression	of	RA-synthesis	(RALDH)	and	RA-degrading	(CYP26)	enzymes	is	used	to	achieve	clearly	demarcated	boundaries	of	active	RA	signaling	in	developing	tissue	(Duester,	2008a;	Rhinn	and	Dolle,	2012).			
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1.6	Retinoic	acid	signaling	in	the	development	of	ocular	tissues	
	 RA	signaling	plays	important	roles	in	the	development	of	many	ocular	tissues,	including	the	retina,	lens,	and	cornea	(Enwright	and	Grainger,	2000;	Kastner	et	al.,	1994;	Wagner	et	al.,	2000).	Proper	eye	morphogenesis	itself	depends	on	RA	(Hyatt	et	al.,	1996b;	Molotkov	et	al.,	2006).	Treatment	of	the	presumptive	eye	field	with	exogenous	RA	will	result	in	anophthalmia	(absence	of	eye	formation),	and	later	treatments	affect	the	differentiation	of	dopaminergic	cells	in	the	retina	(Eagleson	et	al.,	2001).	RA-responsive	reporter	constructs	have	revealed	that	RA	signaling	is	active	in	mice	as	early	as	neural	fold	elevation.	Activity	is	present	in	the	optic	vesicle	and	presumptive	lens	ectoderm	(as	well	as	head	mesenchyme	and	elsewhere)	around	the	time	of	neural	tube	closure	in	the	head	(Enwright	and	Grainger,	2000).	In	zebrafish,	exogenous	RA	treatments	lead	to	aberrant	development	of	the	optic	stalk,	including	persistence	of	the	stalk	that	suggests	an	increase	in	ventral	characteristics.	Localized	RA	treatment	is	sufficient	to	create	a	pseudo-choroid	fissure	at	the	site	of	treatment.	Moreover,	a	ventral	marker	pax(b)	becomes	expressed	in	the	dorsal	retina,	and	a	dorsal	marker	msh(c)	disappears	(Hyatt	et	al.,	1996b).	RA	synthesis	inhibition	using	Citral	results	in	embryos	lacking	a	ventral	retina	(Marsh-Armstrong	et	al.,	1994).	These	data	suggest	that	RA	is	involved	in	establishing	the	ventral	retina,	however	RA	signaling	is	not	itself	responsible	for	establishing	the	dorsoventral	axis	in	the	retina	(Matt	et	al.,	2005;	Molotkov	et	al.,	2006).	Two	phases	of	RA	signaling	govern	the	morphogenesis	of	the	eye;	an	earlier	phase	of	optic	cup	formation	with	RA	generated	in	the	periocular	mesenchyme,	and	a	later	phase	of	anterior	eye	formation,	with	RA	made	in	the	neural	retina	(Duester,	2008b).	It	is	also	responsible	for	differentiation	and	maturation	of	photoreceptor	rods	and	cones	in	zebrafish	(Hyatt	et	al.,	1996a).	Although	RA	is	produced	in	the	corneal	ectoderm	by	RALDH	during	mouse	eye	development,	the	main	target	of	this	RA	is	the	neural	crest-derived	periocular	mesenchyme	(Matt	et	al.,	2005).	Thus	it	appears	that	RA	acts	primarily	as	a	paracrine	signaling	molecule	within	this	context.	Nonetheless	there	is	evidence	that	shows	that	closure	of	the	optic	fissure	is	regulated	by	RA	signaling	in	periocular	mesenchyme	as	well	as	ventral	optic	cup,	
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and	usage	of	an	RAR	inhibitor	results	in	ocular	coloboma	(failure	to	close	choroid	fissure)	(Lupo	et	al.,	2011).	RA	may	also	be	involved	in	late	cornea	development	as	it	can	strongly	induce	the	proliferation	and	stratification	of	keratocytes	in	vitro	in	addition	to	stimulating	collagen	release	(Gouveia	and	Connon,	2013).	Additionally,	studies	in	murine	contexts	have	shown	that	retinoic	acid	induces	crystallin	expression	in	lens	cells	(Gopal-Srivastava	et	al.,	1998).,	and	the	RA	metabolizer	CYP26	is	highly	expressed	in	the	lens	epithelium	of	Xenopus	embryos,	suggesting	a	necessity	of	RA	signaling	ablation	in	those	cells	(Hollemann	et	al.,	1998).				Understanding	the	role	of	RA	signaling	in	establishing	proper	tissue	patterning	has	been	advanced	by	work	done	in	regenerative	biology.	For	instance,	in	the	frog	Rana	temporaria,	treatment	of	the	regenerating	limb	bud	with	RA	results	in	several	duplicated	limbs	(Maden,	1983).	In	Xenopus,	treating	developing	limbs	with	Vitamin	A	leads	to	hypomorphic	development,	but	treating	regenerating	limbs	has	different	effects,	ranging	from	hypomorphia,	to	complete	suppression,	to	skeletal	duplications	(Scadding	and	Maden,	1986).		As	mentioned,	fat-soluble	Vitamin	A	(retinol)	is	the	nutritionally	acquired	precursor	to	retinoic	acid.	It	is	worth	noting	however	that	retinol	has	another	very	important	role	in	the	retina	as	a	photosensitive	molecule	that	participates	in	the	transduction	of	photons	into	electrical	signals	in	rod	and	cone	cells—a	process	known	as	‘the	visual	cycle’	(Saari,	2012).	Popular	recommendations	of	dietary	Vitamin	A	for	eye	health	are	mostly	related	to	this	functional	role	of	retinol	(Evert,	2013;	WHO,	2009),	which	is	completely	distinct	from	its	role	as	a	precursor	to	the	signaling	molecule	RA.	At	the	same	time,	xerophthalmia	(excessive	corneal	dryness)	is	the	leading	cause	of	preventable	childhood	blindness	in	the	world	(WHO,	2009),	and	while	it	is	related	to	dietary	Vitamin	A	deficiency,	it	is	treated	with	topical	retinoic	acid	(Sommer,	1998).	Thus,	other	aspects	of	eye	health	may	also	be	related	to	RA	signaling,	as	many	Vitamin	A	deficiency	associated	eye	diseases	have	unclear	etiologies.		
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1.7	RA	signaling	in	lens	regeneration2		 RA	has	been	shown	to	play	a	necessary	role	in	Wolffian	lens	regeneration	through	the	use	of	small	molecule	inhibitors	such	as	Disulfiram,	which	inhibits	an	RA-synthesis	enzyme	(RALDH),	as	well	as	inhibitors	of	RAR	nuclear	receptors.	While	there	is	almost	certainly	a	redundancy	of	function	of	RAR	receptor	isotypes	within	the	regenerating	lens,	RARα	was	specifically	implicated	when	the	use	of	a	RARα	specific	inhibitor,	AGN194301,	stunted	the	regenerative	capacity	of	the	dorsal	iris	(Tsonis	et	al.,	2000;	Tsonis	et	al.,	2002).	In	many	cases	there	was	a	failure	to	form	a	dedifferentiated	lens	vesicle	from	the	dorsal	iris,	suggesting	a	role	for	RA	in	the	earliest	events	of	regeneration.	Furthermore,	it	is	interesting	to	note	that	the	use	of	a	pan-RAR	antagonist	(AGN193109)	resulted	in	some	cases	of	ectopic	lens	formation,	including	one	case	of	lens	regeneration	from	the	cornea,	reminiscent	of	that	which	takes	place	in	Xenopus.	However,	the	authors	did	not	use	any	tissue-marking	labeling	system	and	the	origin	of	the	lens	was	determined	by	observation	of	histological	sections	alone.	The	appearance	of	a	lens	directly	coming	off	of	some	tissue	is	not	adequate	criteria	for	determining	lens	origin	(Grainger	et	al.,	1988;	Saha	et	al.,	1989),	and	the	observed	result	of	an	ectopic	lens	from	the	cornea	should	be	understood	with	this	caveat	as	they	can	be	fixation	and	sectioning-related	artefacts.	The	effect	was	not	seen	when	the	RARα	specific	antagonist	was	used,	suggesting	that	whatever	function	RARα	might	have	within	the	regenerating	tissue,	it	does	not	involve	defining	the	site	of	lens	formation.	rara	(RARα)	is	not	detected	by	in	situ	analysis	in	unoperated	lenses,	but	it	is	expressed	in	the	lens	epithelial	cells	and	the	fiber	cells	within	the	regenerating	lens,	as	well	as	the	dedifferentiated	lens	vesicle	that	initially	buds	from	the	dorsal	iris	at	the	start	of	regeneration	(Tsonis	et	al.,	2002).	The	same	expression	pattern	is	true	for	RARδ	(the	newt	RARγ),	but	its	functional	role	has	not	been	specifically	investigated	in	the	regenerating	lens.	Work	
                                                
2 Some of the content of this section is excerpted from: Henry, J.J., Thomas, A.G., Hamilton, P.W., Moore, 
L., Perry, K.J., 2013. Cell signaling pathways in vertebrate lens regeneration. Curr Top Microbiol Immunol 
367, 75-98. All excerpted content was authored solely by Alvin G Thomas. 
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remains	to	be	done	to	reveal	what	cellular	or	molecular	mechanisms	the	various	RA	nuclear	receptors	control	in	the	context	of	vertebrate	lens	regeneration.		 Others	have	demonstrated	that	the	normally	lens-incompetent	ventral	iris	of	the	newt	can	be	induced	to	regenerate	lenses	when	transfected	with	six-3,	but	only	when	co-treated	with	retinoic	acid	(Grogg	et	al.,	2005).	These	treatments	forced	the	ventral	iris	to	adopt	patterns	of	gene	regulation	that	are	normally	seen	only	in	the	dorsal	iris	when	it	undergoes	regeneration,	and	the	authors	suggest	that	it	is	this	“dorsalization”	that	renders	the	ventral	iris	capable	of	transdifferentiation.	Since	retinoic	acid	was	necessary	for	this	transformation	to	take	place,	it	can	be	reasoned	that	gene	regulation	by	retinoic	acid	signaling	is	critical	for	conferring	lens-competence	upon	lens-incompetent	tissue.	Taken	together	with	the	earlier	studies	described	above,	it	appears	that	retinoic	acid	is	important	in	all	phases	of	Wolffian	regeneration—acquiring/maintaining	lens	competence,	dedifferentiation	of	the	iris,	and	terminal	differentiation	of	lens	fiber	cells.		The	role	of	retinoic	acid	in	Xenopus	cornea-lens	regeneration	has	been	much	less	understood.	Our	lab	pulled	out	rxrg	(encoding	RXRγ)	from	a	subtracted	cDNA	library	enriched	for	genes	upregulated	in	the	first	four	days	of	regeneration	(Malloch	et	al.,	2009),	but	there	has	otherwise	been	a	lack	of	data	regarding	either	function	or	expression	of	any	RA	signaling	members	within	larval	eye	tissues.	The	work	outlined	in	this	dissertation	fills	this	void	by	investigating	the	role	of	RA	signaling	in	the	context	of	Xenopus	lens	regeneration,	and	describes	a	key	role	for	CYP26	and	RA	signaling	attenuation	in	the	cornea,	and	ultimately	expands	our	knowledge	of	the	regenerative	biology	of	the	vertebrate	lens.							
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Figure	1.1	
	
	(Left)	The	structure	of	a	typical	mammalian	eye.	(Right)	The	eye	of	the	Xenopus	larvae	have	an	inner	and	outer	cornea	as	shown.	Adapted	from	Fukui	and	Henry,	2011	and	Fischer,	2013.																
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Figure	1.2		
	
	The	developmental	scheme	of	the	vertebrate	lens,	and	the	histological	structure	of	a	mature	lens	seen	in	a	transverse	cross-section.	Adapted	from	Graw,	2010.	
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CHAPTER	2	
	
Retinoic	acid	regulation	by	CYP26	in	vertebrate	lens	regeneration3		
Introduction		 Although	mammals	have	a	rather	limited	ability	to	regenerate	lost	or	damaged	tissues,	other	metazoans	exhibit	the	remarkable	capacity	to	regenerate	a	variety	of	tissues,	including	intact	organs.	De	novo	regeneration	of	the	lens	has	been	reported	in	newts,	salamanders,	a	fish,	and	frogs	of	the	genus	Xenopus	(Freeman,	1963;	Henry,	2003).	Upon	removal	of	the	lens,	the	outer	cornea	becomes	exposed	to	molecular	factors	in	the	vitreous	humor	that	are	secreted	by	the	retina,	and	these	factors	induce	the	cornea	to	form	a	new	lens.	The	exact	identities	of	these	factors	are	not	clear,	but	Fibroblast	Growth	Factors	(FGFs)	have	been	implicated	as	both	necessary	(Fukui	and	Henry,	2011)	and	sufficient	(Bosco	et	al.,	1997)	for	lens	regeneration	to	occur.	Additionally,	Bone	Morphogenic	Proteins	(BMP)	signaling	has	been	shown	to	be	critical	for	lens	regeneration	in	Xenopus	(Day	and	Beck,	2011).	However,	the	molecular	factors	that	support	this	process	and	make	the	cornea	competent	to	respond	to	these	retinal	factors	are	much	less	understood.			
All-trans	Retinoic	Acid	(RA)	plays	various	roles	in	the	development	of	ocular	tissues.	Morphogenesis	of	the	eye,	as	well	as	the	development	of	the	retina,	lens,	and	cornea,	have	all	been	shown	to	be	orchestrated	by	RA	signaling	(Enwright	and	Grainger,	2000;	Hyatt	et	al.,	1996b;	Kastner	et	al.,	1994;	Molotkov	et	al.,	2006;	Wagner	et	al.,	2000).	RA	signaling	has	been	implicated	in	the	process	of	vertebrate	lens	regeneration	as	well,	when	Tsonis	and	colleagues	found	evidence	that	RA	
                                                
3 The contents of this chapter has been published in: Thomas, A.G. , Henry. J.J. , 2014. 
“Retinoic acid regulation by CYP26 in vertebrate lens regeneration”. Dev Biol. 2014 Feb 
15; 386(2): 291–301. It is excerpted here in its entirety with permission from the 
publisher. 
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signaling	is	necessary	for	lens	regeneration	in	the	newt	(Tsonis	et	al.,	2000;	Tsonis	et	al.,	2002).	In	the	case	of	newts	and	salamanders,	lens	regeneration	occurs	via	transdifferentiation	of	the	dorsal	pigmented	iris	epithelium.	Remarkably,	the	ventral	iris	of	the	newt,	which	is	normally	incapable	of	regenerating	a	lens,	can	also	give	rise	to	lens	cells	when	they	are	made	to	express	six3	in	the	presence	of	exogenous	RA	(Grogg	et	al.,	2005).	Although	the	process	of	lens	regeneration	in	Xenopus	has	traditionally	been	described	as	involving	transdifferentiation	of	the	differentiated	cornea	epithelium,	recent	studies	suggest	that	a	population	of	multipotent	corneal	stem	cells	or	their	transient	amplifying	progeny	may	be	the	source	of	the	regenerated	lens	(Perry	et	al.,	2013).	Previously,	we	identified	a	specific	nuclear	receptor	involved	in	RA-signaling	(rxrg)	in	a	subtracted	cDNA	library	representing	genes	upregulated	in	the	cornea	during	Xenopus	lens	regeneration	(Malloch	et	al.,	2009).	The	collective	data	seems	to	indicate	an	important	role	for	RA	signaling	in	tissues	that	regenerate	a	lens.		The	biological	source	of	retinoids	in	animals	is	dietary	Vitamin	A	(retinol).	Once	inside	the	cell,	retinol	can	be	oxidized	to	retinaldehyde	by	retinol	dehydrogenase	enzymes	(RDH),	and	further	oxidized	into	RA	by	retinaldehyde	dehydrogenases	(RALDH).	RA	effects	its	influence	on	the	cell	by	binding	to	Retinoic	Acid	Receptors	(RARα/β/γ)	and	Retinoid	X	Receptors	(RXRα/β/γ),	that	can	homo-	or	heterodimerize	in	limited	combinations	to	bind	to	specific	DNA	motifs	in	the	genome	known	as	Retinoic	Acid	Response	Elements	(RAREs)	(reviewed	by	Bastien	and	Rochette-Egly,	2004)	.	The	RA	nuclear	receptors	can	act	as	either	transcriptional	repressors,	or	transcriptional	activators	in	different	contexts.	Moreover,	RA	can	exert	its	influence	at	different	locations	than	where	it	was	produced,	by	binding	to	Cellular	Retinoic	Acid	Binding	Protein	(CRABP)	and	being	transported	out	of	these	cells.	Thus,	RA	can	act	as	both	an	autocrine	and	paracrine	signal.	A	cytochrome	P450	superfamily	enzyme,	CYP26,	metabolizes	RA	within	the	cell	and	thereby	regulates	RA	levels	in	a	time	and	tissue	specific	manner	(Cvekl	and	Wang,	2009;	Niederreither	and	Dolle,	2008).	Careful	coordination	of	RA	synthesis	and	metabolism	establishes	cell	or	tissue-specific	patterns	of	RA	signaling	within	an	
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animal	(Duester,	2008;	Rhinn	and	Dolle,	2012).	The	activity	of	CYP26	is	important	for	proper	embryonic	development	by	establishing	boundaries	of	RA	signaling.	CYP26	is	highly	expressed	in	the	lens	epithelium	of	Xenopus	embryos,	suggesting	a	necessity	of	RA	signaling	ablation	in	those	cells	(Hollemann	et	al.,	1998),	although	the	reason	for	that	is	presently	unclear.				 Although	RA	has	been	implicated	in	the	process	of	lens	regeneration	in	newts,	its	role	in	Xenopus	cornea-lens	regeneration	is	not	understood.	In	the	present	study	we	implicate	RA	metabolism	mediated	through	CYP26	as	a	necessary	event	for	lens	regeneration	to	occur	in	Xenopus,	using	a	pharmacological	inhibitor	of	CYP26,	as	well	as	exogenous	RA,	and	a	synthetic	retinoid,	TTNPB.	Further,	we	examine	the	effects	of	these	compounds	on	cell	proliferation,	and	expression	of	putative	stem	cell	markers.	We	also	characterize	the	localization	of	RALDH	and	CYP26	proteins	within	the	cornea.		
Materials	and	Methods	
	
Animals	
Xenopus	laevis	adult	frogs	were	acquired	from	Nasco	(Fort	Atkinson,	WI).	X.	
laevis	embryos	and	larvae	were	raised	following	Henry	and	Grainger	(1987)	,	and	Henry	and	Mittleman	(1995)	.	All	staging	is	according	to	Niewkoop	and	Faber	(1956).		
Reverse	Transcriptase-Polymerase	Chain	Reaction	(RT-PCR)	analysis	
X.	laevis	larvae	of	stages	48-50	were	anesthetized	in	1:2000	MS-222	(Sigma,	St.	Louis,	MO)	diluted	in	1/20	Normal	Amphibian	Media	(NAM;	Slack,	1984).	Corneas	were	excised	with	fine	iridectomy	scissors	and	flash-frozen	in	a	dry	ice/ethanol	bath	at	-80ºC.	“Control”	cornea	tissue	was	obtained	by	collecting	and	freezing	corneas	from	unoperated	animals.	For	“Regenerating”	corneal	tissue,	stage	48-50	tadpoles	were	lentectomized,	and	corneas	from	the	operated	eyes	were	removed	and	collected	at	1,	3,	and	5	days	post-lentectomy,	and	pooled	together	for	
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RNA	extraction.	RNA	was	extracted	from	the	samples	by	homogenization	in	TRIzol	(Ambion,	Grand	Island,	NY)	and	processed	using	Direct-zol	RNA	MiniPrep	columns	(Zymo	Research,	Irvine,	CA).	Each	sample	was	then	treated	with	DNAse	I	(New	England	Bioloabs,	Ipswich,	MA)	to	remove	any	possible	genomic	DNA	contamination,	and	run	through	a	NucAway	Spin	column	(Ambion,	Austin,	TX)	to	remove	reaction	contaminants.	cDNA	was	synthesized	from	the	RNA	using	an	iScript	cDNA	synthesis	kit	(BioRad,	Hercules,	CA).	Half	of	the	RNA	from	each	sample	was	used	for	“-RT”	control	cDNA,	which	employed	the	iScript	cDNA	synthesis	kit,	but	with	water	in	place	of	the	supplied	reverse	transcriptase	enzyme.	“Lens”	RNA	was	obtained	similarly,	from	lenses	isolated	from	stage	49-52	tadpoles.	As	a	positive	control	for	all	primer	sets,	“Embryonic”	RNA	was	harvested	similarly,	using	pooled	stage	1-33	embryos.	PCRs	were	run	in	50µl	volumes	for	30	rounds	using	7ng	of	input	cDNA	template.	GAPDH	was	used	as	a	positive	control	for	each	sample	of	cDNA.	Sequences	of	primer	pairs	and	the	melting	temperatures	used	for	each	are	listed	in	Supplemental	Table	1.	The	identity	of	every	PCR	band	was	confirmed	by	DNA	sequencing	at	the	Roy	J.	Carver	Biotechnology	Center	(University	of	Illinois,	Urbana,	Illinois).		
In	vitro	lens	regeneration	assay	The	in	vitro	lens	regeneration	assays	using	pharmacological	inhibitors	were	performed	as	outlined	in	Fukui	and	Henry	(2011),	with	some	variations.	Briefly,	animals	were	anesthetized	in	1:2000	MS-222	(Sigma,	St.	Louis,	MO)	diluted	in	1/20	NAM.	Incisions	were	made	using	fine	iridectomy	scissors	in	the	outer	cornea	and	the	lens	was	removed.	The	outer	cornea	was	then	tucked	into	the	empty	vitreous	chamber	and	the	whole	eye	was	then	excised,	and	placed	into	a	well	of	a	24-well	tissue	culture	plate.	Eyes	were	separately	cultured	for	7	days	in	350µl	of	modified	L-15	media	(2:3	dilution	of	L-15	media,	with	10%	fetal	bovine	serum,	2.5µg/ml	Amphotericin,	10kU/ml	penicillin-streptomycin,	and	4µg/ml	Marbofloxacin)	supplemented	with	the	appropriate	concentration	of	pharmacological	compound	or	vehicle	(DMSO).	The	following	6	experimental	conditions	were	tested:	100µM	Liarozole	Hydrochloride	(Tocris,	Bristol,	UK),	20µM	TTNPB	(Tocris),	1µM	all-trans	
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Retinoic	acid	(Sigma),	20µM	all-trans	Retinoic	acid,	60µM	Citral	(Sigma),	5µM	LE-135	(Tocris).	Culture	media	was	changed	daily,	and	after	7	days	of	culture,	eyes	were	rinsed	briefly	with	PBS	and	fixed	in	3.7%	formaldehyde	for	2	hours	at	25ºC.	Eyes	were	then	dehydrated	in	ethanol,	later	cleared	with	xylene,	and	subsequently	embedded	in	paraffin	wax.	Eyes	were	sectioned	at	a	thickness	of	9µm	and	placed	onto	a	positively	charged	microscope	slide	(Colorfrost	Plus,	Thermo	Scientific,	Kalamazoo,	MI)	for	immunohistochemical	staining	with	a	polyclonal	anti-lens	antibody	(Henry	and	Grainger,	1990).	Imaging	was	done	using	a	Zeiss	Axioplan	light	microscope.	The	presences	of	morphologically	distinct	lentoid	structures	that	positively	stained	with	the	antibody	were	scored	as	successful	cases	of	lens	regeneration.	Statistical	significance	in	differences	between	regeneration	rates	was	established	using	(two-tailed)	Fisher’s	Exact	test.		
Quantitative	RT-PCR	(qPCR)	Corneas	were	cut	around	the	periphery	of	the	eye	from	stage	48-51	tadpoles,	leaving	the	cornea	epithelium	attached	to	the	eye	via	the	central	corneal	stalk.	Then,	the	whole	eye	was	excised	from	the	animal	and	placed	into	modified	L-15	culture	media	containing	an	appropriate	concentration	of	pharmacological	compound	or	the	DMSO.	The	following	conditions	were	tested:	100µM	Liarozole,	20µM	TTNPB,	1	µM	all-trans	Retinoic	acid,	20µM	all-trans	Retinoic	acid,	with	0.2%	DMSO	as	a	control	condition.	Additionally	we	tested	60µM	Citral	and	5µM	LE-135,	with	0.05%	DMSO	as	a	control	condition.	For	each	condition,	20-25	eyes	were	cultured	together	in	small	petri	dishes	containing	3ml	of	culture	media.	After	4	days	of	culture	the	corneas	were	surgically	removed	from	each	eye	and	placed	into	a	microcentrifuge	tube	immersed	in	ethanol	and	dry	ice,	as	described	above.	RNA	was	extracted	and	processed	from	each	pool	of	corneas	and	cDNA	was	generated	in	the	same	manner	as	described	above.			 All	qPCR	experiments	were	performed	3-4	times,	with	technical	replicates	receiving	10-25ng	of	input	cDNA.	SYBR	Green	reagent	(kindly	provided	by	Dr.	Jie	Chen,	University	of	Illinois	at	Urbana-Champaign)	was	used	along	with	125nM	of	
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forward	primers	and	500nM	of	reverse	primers	for	actb	and	cyp26a1,	and	500nM	of	both	primers	for	sox2,	oct60,	and	p63.	All	primers	are	listed	in	Supplemental	Table	1.	
actb	(beta-actin)	was	used	as	the	internal	control	gene	in	every	experiment,	and	the	expression	of	the	test	gene	under	each	drug-treated	condition	was	normalized	to	the	expression	of	that	same	gene	in	the	control	condition.	Melting-curve	analysis	was	conducted	for	each	experiment.	Fold	changes	of	expression	were	determined	using	the	comparative	CT	method	(Schmittgen	and	Livak,	2008).	Statistical	significance	was	established	using	the	(unpaired)	t	test.		
Immunohistochemistry	Stage	50-51	animals	were	fixed	in	3.7%	formaldehyde	for	30	minutes	at	25ºC.	Whole	eyes	were	then	excised	and	processed	with	the	cornea	still	attached	at	the	corneal	stalk.	All	steps	of	processing	were	done	in	a	1X	PBS	buffer	with	0.2%	Triton	X-100.	Eyes	were	blocked	in	a	solution	of	5%	bovine	serum	albumin	and	5%	normal	goat	serum.	All	primary	antibody	incubations	were	done	overnight	at	4ºC,	and	secondary	antibody	incubations	were	1-2	hours	at	25ºC.	Primary	antibodies	included	polyclonal	rabbit-anti-CYP26A	(1:200	dilution;	Abcam,	Cambridge,	MA),	polyclonal	rabbit-anti-CYP26B	(1:100	dilution;	Abcam),	and	polyclonal	mouse-anti-RALDH1	(1:200	dilution;	Abcam).	Western	blot	analysis	using	cornea	and	embryonic	protein	extracts	revealed	appropriately	sized	bands	for	each	of	these	antibodies	(Fig.	S1).	The	following	secondary	antibodies	were	used:	Alexa	Fluor	488	goat-anti-mouse,	and	Alexa	Fluor	488	goat-anti-rabbit	(1:500	dilution;	Life	Technologies,	Grand	Island,	NY).	Cell	boundaries	were	visualized	with	the	addition	of	1:150	rhodamine-conjugated	phalloidin	(Cytoskeleton,	Denver,	CO),	added	separately	after	secondary	antibody	incubation,	overnight	at	4ºC.	Nuclei	were	visualized	by	staining	the	tissue	in	DAPI	for	15	minutes	at	25ºC	(1µM;	Sigma,	St.Louis,	MO).	After	processing,	the	corneas	were	gently	lifted	off	of	the	eyes	using	fine	forceps	and	were	placed	into	a	drop	of	mounting	media	(ProLong	Gold;	Invitrogen,	Eugene,	OR)	placed	on	charged	slides	(Colorfrost	Plus,	Thermo	Scientific,	Kalamazoo,	MI).	A	coverslip	was	then	placed	on	top	of	each	cornea,	and	pressed	
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downward	to	flatten	the	tissue	before	being	left	to	cure	overnight	at	25ºC.	Imaging	was	done	on	a	Zeiss	LSM-700	confocal	microscope.		
Measuring	cell	division	with	phospho-Histone	H3	staining	Corneas	were	cut	around	the	periphery	of	the	eye	from	stage	48-50	tadpoles,	leaving	the	cornea	epithelium	attached	to	the	eye	via	the	central	corneal	stalk.	Then,	the	whole	eye	was	excised	from	the	animal	and	placed	into	modified	L-15	culture	media	containing	an	appropriate	concentration	of	pharmacological	compound	or	DMSO.	The	following	conditions	were	tested:	100µM	Liarozole,	20µM	TTNPB,	1	µM	all-trans	Retinoic	acid,	20µM	all-trans	Retinoic	acid,	with	0.2%	DMSO	as	a	control	condition.	3-4	eyes	at	a	time	were	cultured	in	1mL	of	culture	media.	After	4	days	of	culture,	the	eyes	were	rinsed	briefly	in	PBS,	fixed	in	3.7%	formaldehyde	for	2	hours,	and	stained	using	rabbit	anti-phospho-Histone	H3	(1:200	dilution;	Kindly	provided	by	Dr.	Craig	Mizzen,	University	of	Illinois	at	Urbana-Champaign)	in	the	same	manner	described	above,	with	two	modifications:	nuclei	were	visualized	by	staining	with	Hoechst	(1:10,000	dilution;	Molecular	Probes,	Eugene,	OR)	for	20	minutes,	and	imaging	was	done	on	a	Zeiss	Axioplan	microscope.		 Quantification	of	cell	division	was	performed	by	first	sampling	a	standardized	square	area	within	the	cornea	in	each	image	to	measure	the	nuclear	density	of	that	cornea.	Then,	the	total	number	of	nuclei	in	each	cornea	was	determined	by	multiplying	the	calculated	nuclear	density	by	the	total	area	of	that	cornea,	as	measured	using	ImageJ	(U.S.	National	Institutes	of	Health,	Bethesda,	MD).	Total	number	of	mitotic	figures	in	each	cornea	was	counted	manually.	The	total	number	of	mitotic	figures	per	100	nuclei	(MFN)	was	used	as	a	measure	of	cell	division.	The	MFN	was	determined	for	each	individual	case,	and	the	mean	MFN	was	calculated	for	every	experimental	condition.	Pericorneal	tissue	was	excluded	from	the	analysis.	Statistical	significance	was	established	using	the	(unpaired)	t	test.				
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Results	
	
Expression	of	RA	regulation	related	transcripts	in	Xenopus	eye	tissues	
	 RT-PCR	was	performed	to	examine	the	expression	of	the	transcripts	of	
aldh1a1/2/3,	which	encode	the	enzyme	that	acts	in	the	final	step	of	endogenous	RA	synthesis,	and	the	point	at	which	tissue-specific	patterning	of	an	RA	presence	is	generally	regulated	(see	review	by	Niederreither	and	Dolle,	2007)	.	We	also	examined	transcripts	of	cyp26a/b/c1,	which	metabolize	endogenous	RA	(White	et	al.,	1996).		The	expression	of	these	members	of	RA	biosynthesis	and	metabolism	allow	one	to	infer	changes	in	the	regulation	of	RA	signaling	within	a	given	tissue.	Three	isotypes	exist	for	both	enzymes	in	Xenopus,	encoded	by	6	distinct	genes,	so	primers	were	designed	to	examine	all	6	independently.	aldh1a1,	aldh1a2,	and	
aldh1a3	(encoding	RALDH1,	RALDH2,	and	RALDH3	respectively)	are	all	expressed	in	“Control”	corneas	harvested	from	unlentectomized	eyes,	as	well	as	“Regenerating”	corneas	collected	and	pooled	from	1,	3,	and	5	days	post-lentectomy	(Fig.	2.1A).	cyp26a1	and	cyp26b1	(encoding	CYP26A	and	CYP26B,	respectively),	but	not	cyp26c1	(CYP26C),	are	expressed	in	the	cornea	in	both	control	and	regenerating	tissues.	The	expression	of	these	genes	was	also	examined	in	harvested	lenses,	where	all	of	the	genes	except	aldh1a3	were	found	to	be	expressed	(Fig.	2.1B).		
RA	signaling	activation	via	CYP26	inhibition	or	application	of	exogenous	
retinoids	can	both	inhibit	lens	regeneration	
		 In	order	to	investigate	the	necessity	of	RA	regulation	by	CYP26,	lentectomized	eyecups	were	cultured	in	the	presence	of	various	inhibitors	and	activators	in	an	in	vitro	culture	system	described	in	Fukui	and	Henry	(2011).	Eyes	were	cultured	in	the	presence	of	100µM	Liarozole	Hydrochloride,	an	antagonist	of	CYP26.	Treatment	with	Liarozole	profoundly	inhibited	lens	regeneration	(p<0.0001).	Only	1/23	(4%)	eyes	regenerated	a	lens	in	the	drug-treated	condition,	compared	to	13/20	(65%)	with	DMSO	(Fig.	2.2A,	Fig.	2.3	A-D).	This	result	strongly	
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implicates	a	necessary	role	for	CYP26	activity	within	the	eye,	suggesting	that	RA	levels	need	to	be	reduced	in	the	cornea	for	lens	formation	to	occur.			 To	assess	whether	the	diminished	regeneration	is	the	result	of	CYP26	antagonism,	we	cultured	the	eyecups	with	TTNPB,	a	potent	retinoic	acid	analog	(Minucci	et	al.,	1996;	Pignatello	et	al.,	1999),	which	is	highly	resistant	to	the	metabolizing	action	of	CYP26	(Pignatello	et	al.,	2002).	Since	the	molecular	consequence	of	CYP26	antagonism	should	lead	to	a	rise	of	endogenous	RA,	we	assessed	whether	the	addition	of	CYP26-resistant	TTNPB	could	impart	the	same	consequence	on	regeneration	as	Liarozole.	Results	show	that	treatment	of	eyes	with	20µM	TTNPB	greatly	reduced	lens	regeneration	(p<0.0001)	as	only	4/35	(11%)	eyes	regenerated	lenses,	compared	to	22/32	(69%)	with	DMSO	(Fig.	2.2A,	Fig.	2.3	
E-H).	We	likewise	examined	whether	exogenous	RA	would	inhibit	regeneration.	A	relatively	low	concentration	(1µM)	of	RA	failed	to	do	so,	as	21/30	(70%)	treated	eyes	regenerated,	compared	with	17/29	(59%)	DMSO-treated	eyes.	The	apparent	slight	increase	in	regeneration	is	notably	not	statistically	significant	(p=0.40).	However,	a	higher	concentration	(20µM)	of	RA	very	strongly	inhibited	lens	regeneration,	as	0/33	(0%)	eyes	regenerated	when	treated	with	20µM	RA,	compared	to	18/33	(55%)	of	eyes	treated	with	DMSO	(p<0.0001)	(Fig.	2.2A,	Fig.	
2.3	I-P).			 To	demonstrate	that	Liarozole	and	retinoid	treatments	were	actually	affecting	the	RA	signaling	pathway,	we	performed	a	drug-treatment	validation	assay	to	examine	the	expression	of	cyp26a1.	Cyp26	genes	are	known	to	respond	robustly	to	retinoic	acid	(de	Roos	et	al.,	1999;	Hollemann	et	al.,	1998;	Pavez	Loriè	et	al.,	2009),	so	we	checked	for	overexpression	of	cyp26a1	in	drug-treated	tissue	samples	to	confirm	activation	of	RA	signaling.	qPCR	was	performed	using	RNA	extracted	from	corneas	that	were	treated	with	either	drug	or	vehicle	for	4	days.	All	compounds	used	showed	a	marked	increase	in	cyp26a1	expression,	as	Liarozole-treated	corneas	had	100-fold	increase	(p=0.0007),	and	TTNPB	had	over	1000-fold	increase	(p=0.0005)	compared	to	control	corneas.	Additionally,	both	1µM	and	20µM	
  41 
RA	treatments	showed	over	1000-fold	increase	in	cyp26a1	expression	(p=0.001	and	
p=0.008,	respectively).	There	was	no	statistically	significant	difference	in	the	expression	levels	between	1µM	and	20µM	RA	(Fig.	2.2B).	This	result	demonstrates	that	all	of	the	drug	treatments	have	an	ultimate	molecular	consequence	of	increasing	retinoid	signaling	within	the	cornea.	This	increase	in	RA	signaling	is	correlated	above	with	a	failure	to	regenerate	lenses	from	the	cornea	epithelium,	with	the	exception	of	1µM	RA,	which	despite	the	increase	in	RA	signaling	does	not	inhibit	lens	regeneration.	This	shows	that	while	cyp26a1	over-expression	is	a	positive	readout	of	increased	RA	signaling	and	drug	treatment	efficacy,	elevated	expression	of	cyp26a1	does	not	in	itself	inhibit	lens	regeneration.			 We	also	treated	cases	with	inhibitors	of	RA-signaling.	Treatment	with	60µM	Citral,	an	inhibitor	of	RA	synthesis,	did	not	inhibit	lens	regeneration	(p=0.44),	as	12/18	(64%)	of	Citral-treated	eyes	regenerated	compared	to	15/18	(83%)	of	eyes	treated	with	vehicle	alone.	Likewise,	5µM	of	LE-135,	an	antagonist	of	the	RA	nuclear	receptors	RARα	and	RARβ,	failed	to	inhibit	lens	regeneration	(p=0.48),	as	19/24	(79%)	LE-135-treated	eyes	regenerated	lenses,	compared	to	12/18	(66%)	of	those	treated	with	DMSO	(Fig.	2.2C,	Fig.	2.3	Q-X).	These	results	are	consistent	with	our	hypothesis	and	suggest	that	antagonism	of	RA	signaling	does	not	prevent	lens	regeneration	from	occurring	in	the	eye.			 Additionally	we	assessed	whether	these	compounds	acted	upon	the	RA	signaling	pathway	using	qPCR.	Corneas	treated	with	LE-135	expressed	only	half	as	much	cyp26a1	compared	to	controls	(p<0.0001).	This	suggests	that	RA-receptor	antagonism	does	not	itself	lead	to	a	decrease	in	lens	regeneration.	However,	
cyp26a1	expression	was	unaffected	for	Citral-treated	corneas	(Fig.	2.2D).					
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The	effect	of	CYP26	inhibition	and	exogenous	retinoids	on	cell	proliferation	in	
the	cornea	
	 We	examined	the	effects	of	Liarozole,	TTNPB,	and	RA	upon	cell	division	corneas	by	culturing	them	in	the	presence	of	the	compounds	in	vitro	for	4	days	and	measuring	cellular	division.	Phosphorylated	Histone	H3	is	a	reliable	marker	of	cell	division	(Hans	and	Dimitrov,	2001),	so	we	used	an	α-phospho-Histone	H3	antibody	to	visualize	and	count	mitotic	cells	in	the	corneas.	The	metric	we	used	in	quantifying	changes	in	cell	division	was	to	measure	the	number	of	Mitotic	Figures	for	every	100	
Nuclei	in	the	cornea	(MFN),	which	allows	us	to	control	for	the	variation	in	nuclear	density	and	number	across	individual	corneas.	Corneas	cultured	with	DMSO	had	a	mean	MFN	of	1.9	(n=9),	and	no	statistically	significant	difference	was	measured	for	treatment	with	TTNPB	(mean	MFN=1.44;	n=7),	1µM	RA	(mean	MFN	=	1.66;	n=8),	or	20µM	RA	(mean	MFN=	1.45;	n=6)	(Fig.	2.4).	Treatment	with	Liarozole	however	reduced	cell	division	in	half	(mean	MFN=0.89;	n=9;	p<0.0001).		Since	only	Liarozole	treatment,	and	not	exogenous	retinoids,	resulted	in	a	reduction	of	cell	division,	the	decrease	in	cell	division	is	not	due	to	the	rise	in	endogenous	RA	that	results	from	CYP26	antagonism.	Moreover,	a	reduction	in	cell	division	does	not	necessarily	result	from	altered	RA	levels.		
The	effect	of	CYP26	inhibition	and	exogenous	retinoids	on	the	expression	of	
putative	stem	cell	markers	
	 We	performed	qPCR	to	assess	whether	the	expression	of	3	putative	corneal	stem	cell	markers—sox2,	oct60,	and	p63	(Perry	et	al.,	2013)	—was	affected	by	the	drug	treatments	in	vitro.	A	small	increase	in	expression	was	observed	for	sox2	when	corneas	were	treated	with	TTNPB	(3-fold;	p<0.0001),	1µM	RA	(2.75-fold;	p<0.0001),	and	20µM	RA	(2.15-fold;	p<0.0001).	Liarozole	treatment	did	not	affect	the	expression	of	sox2.	The	expression	of	oct60	decreased	with	1µM	RA	(0.6-fold;	
p=0.02)	and	20µM	RA	(0.45-fold;	p=0.0007).	Neither	Liarozole	nor	TTNPB	affected	the	expression	of	oct60.	The	expression	of	p63	decreased	with	1µM	RA	(0.6-fold;	
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p=0.002)	and	20µM	RA	(0.4-fold;	p<0.0001).	Neither	Liarozole	nor	TTNPB	affected	the	expression	of	p63	(Fig.	2.5).	Since	Liarozole	inhibited	lens	regeneration	but	did	not	affect	the	expression	of	any	of	these	3	genes,	and	1µM	RA	did	not	inhibit	regeneration	but	did	affect	the	expression	of	all	3	genes,	it	appears	that	the	impact	of	altered	RA	signaling	on	lens	regeneration	is	not	directly	related	to	the	expression	of	these	3	genes	in	the	cornea.		
Localization	of	CYP26	and	RALDH	in	the	cornea	epithelium	
		 Since	CYP26	function	appeared	to	be	necessary	for	lens	regeneration,	we	next	examined	the	possible	sites	of	RA	metabolism	with	immunohistochemical	staining	of	CYP26.	We	recently	described	that	the	Xenopus	cornea	is	constructed	of	3	distinctly	identifiable	layers	of	cells	(Perry	et	al.,	2013),	so	we	employed	whole	mount	immunohistochemical	staining	of	cornea	pelts	and	confocal	microscopy	to	visualize	subcellular	localization	of	proteins	within	corneal	tissue.	
		 Staining	with	α-CYP26A	antibody	revealed	CYP26A	localization	in	both	the	outer	and	basal	layers	of	the	cornea	epithelium	(Fig.	2.6A,	B).	Furthermore,	staining	was	seen	in	the	sparse	cells	of	a	deeper	fibrillar	layer	that	lies	beneath	the	basal	epithelium	(Fig.	2.6C,	arrowheads).	In	contrast,	use	of	an	α-CYP26B	polyclonal	antibody	showed	that	CYP26B	does	not	localize	to	the	cells	of	the	fibrillar	layer	(Fig.	
2.6F,	arrowheads)	although	it	does	stain	the	other	two	cellular	layers	(Fig.	2.6D,	E).			 Finally	we	examined	the	possible	site	of	RA	synthesis	within	the	cornea	using	an	α-RALDH1	antibody.	Staining	revealed	RALDH1	localization	in	cells	of	the	outer,	and	basal	layers,	but	not	the	fibrillar	layers	of	cells,	in	a	pattern	that	was	highly	similar	to	that	of	CYP26B	(Fig.	6G,	H,	I).					
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Discussion	
	 Much	of	what	is	currently	known	about	the	roles	of	RA	signaling	in	the	development	of	the	vertebrate	eye	comes	from	expression	analyses	and	knockout	experiments	in	mouse	embryos	(Cvekl	and	Wang,	2009;	Duester,	2008;	Ross	et	al.,	2000).	In	Xenopus,	RA	affects	eye	field	and	telencephalon	field	development	and	has	a	stronger	influence	on	the	ventral	aspect	of	these	fields	(Eagleson	et	al.,	2001).	Regions	of	RA	signaling	activity	also	coincide	with	regions	of	Pax6	expression,	and	
Pax6-mutant	tissues	exhibit	defective	retinoid	production.	Mice	with	mutated	Pax6	have	reduced	RA	signaling	in	the	developing	eye,	with	particularly	serious	effects	in	the	lens	(Enwright	and	Grainger,	2000),	and	RA	induces	the	expression	of	αB-
Crystallin,	a	marker	of	murine	lens	cells,	in	vitro	(Gopal-Srivastava	et	al.,	1998).		 	In	Xenopus,	it	is	known	that	RA,	FGF	receptor,	and	Hedgehog	signaling	pathways	all	serve	to	ventralize	the	developing	eye	(Lupo	et	al.,	2005).	Later	in	development,	the	mouse	retina	has	dorsal	and	ventral	zones	rich	with	RA,	with	a	horizontal	band	of	RA-poor	cells,	all	established	via	coordinated	expression	of	RALDH	and	CYP26	enzymes	(Sakai	et	al.,	2004;	Wagner	et	al.,	2000).	RA	signaling	components,	including	Raldh	and	Cyp26	genes,	are	expressed	throughout	the	embryo	during	Xenopus	organogenesis	(Lynch	et	al.,	2011).			 RA	signaling	has	been	implicated	in	the	regeneration	of	several	tissues	as	well.	The	application	of	Disulfiram,	another	RA	synthesis	inhibitor,	inhibits	the	regeneration	of	tadpole	tails	in	Xenopus	as	well	as	limbs	in	axolotls	(Maden,	1998).	Application	of	retinoids	such	as	Vitamin	A	or	TTNPB	cause	fully	formed	limbs	to	sprout	in	place	of	a	tail	in	Rana	temporaria	(Maden	and	Corcoran,	1996).	Similarly,	application	of	Vitamin	A	and	RA	both	result	in	duplications	of	limbs	when	applied	during	the	course	of	limb	regeneration	in	axolotls	(Maden,	1983).	In	our	own	lab	we	have	observed	that	Disulfiram	fails	to	inhibit	lens	regeneration	when	live,	lentectomized	Xenopus	tadpoles	are	kept	in	water	containing	an	even	higher	concentration	(10µM)	of	the	compound	than	what	was	used	in	the	above	studies	
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(data	not	shown).	Here	we	report	that	RA	synthesis	inhibition	via	Citral	has	the	same	null	effect	on	lens	regeneration	in	vitro.	Likewise,	treatment	with	another	RA	inhibitor,	LE-135,	also	did	not	affect	lens	regeneration	(Fig.	2.2C).			 Lens	regeneration	in	newts	(Wolffian	lens	regeneration)	occurs	via	transdifferentiation	of	the	dorsal	iris	pigmented	epithelial	cells,	following	exposure	to	factors	provided	by	the	retina	(Tsonis	et	al.,	2004).	RA	signaling	has	been	established	as	a	necessary	signaling	scheme	during	this	process,	as	application	of	a	RARα	inhibitor	greatly	reduced	the	regenerative	potential	of	the	dorsal	iris,	and	application	of	a	pan-RAR	antagonist	greatly	inhibited	regeneration	and	sometimes	caused	ectopic	lens	formation	following	lens	removal.	In	one	case,	a	lens	regenerated	from	the	cornea	instead	of	the	dorsal	iris,	corroborating	our	finding	here	that	RA	signaling	attenuation	is	supportive	of	lens	regeneration	from	the	cornea.	Moreover,	addition	of	exogenous	retinoids	had	no	effect	on	newt	lens	regeneration	(Tsonis	et	al.,	2000;	Tsonis	et	al.,	2002).	The	importance	of	RA	in	Wolffian	regeneration	was	further	demonstrated	when	RA	treatment	together	with	
six3	expression	transformed	the	normally	lens-incompetent	ventral	iris	into	lens	regeneration-competent	tissue	(Grogg	et	al.,	2005).	In	contrast,	the	present	study	demonstrates	that	active	RA	signaling	is	prohibitive	for	lens	regeneration	in	
Xenopus.			 RT-PCR	data	indicate	that	RALDH1-3	are	all	present	in	both	control	and	regenerating	corneas.	RALDH1	and	RALDH2	are	both	present	in	the	lens,	but	RALDH3	is	absent,	suggesting	that	there	might	be	a	reduced	need	for	RA	production	in	lens	tissue.	CYP26C	is	also	expressed	in	the	lens,	unlike	control	and	regenerating	corneas,	which	express	only	CYP26A	and	CYP26B,	and	thus	the	lens	expresses	all	3	RA-degrading	enzymes	(Fig.	1B).	It	is	possible	that	during	the	course	of	lens	differentiation	from	corneal	tissue,	it	becomes	necessary	to	reduce	the	rate	of	production	of	RA,	and	to	increase	the	removal	of	RA	from	these	tissues,	and	this	is	accomplished	through	regulated	expression	of	the	various	RALDH	and	CYP26	enzymes.	Although	CYP26C	can	bind	and	degrade	9-cis-RA,	all-trans	RA	is	its	
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preferred	substrate	(Taimi	et	al.,	2004).	In	Xenopus	embryos	the	developing	lens	expresses	cyp26a1,	specifically	within	the	lens	epithelium,	likely	to	moderate	the	effects	of	RA	in	that	region	(Hollemann	et	al.,	1998;	Lynch	et	al.,	2011).				 Here,	immunohistochemical	staining	revealed	the	presence	of	CYP26A	and	CYP26B	in	both	the	outer	and	basal	layers	of	the	cornea	epithelium	(Fig.	2.6).	The	granular	staining	patterns	observed	in	these	cells	is	characteristic	of	the	known	staining	pattern	of	endosome-localized	cytochrome	P450	enzymes	in	the	cytoplasm	(Makwana	et	al.,	2012;	Yague	et	al.,	2004).	CYP26A	and	CYP26B	could	act	to	eliminate	an	unwanted	influence	of	RA	in	these	cells.	CYP26A,	unlike	CYP26B,	is	also	found	in	the	cells	of	the	fibrillar	layer.	Although	the	identity	and	function	of	these	deeper	cells	is	not	clear,	they	may	be	keratinocytes.	Basal	keratinocytes	of	human	skin	express	CYP26A,	which	carefully	modulates	the	levels	of	skin	RA	(Heise	et	al.,	2006).	Relative	to	CYP26B,	CYP26A	has	significantly	higher	catalytic	activity	for	metabolizing	RA	into	the	metabolite	4-oxo-RA	(Topletz	et	al.,	2012).	The	presence	of	the	more	highly	active	CYP26A	enzyme	in	the	cells	of	the	fibrillar	layer	may	highlight	the	urgency	of	RA	disposal	in	those	cells.	This	is	further	corroborated	by	the	inducibility	of	CYP26A	by	retinoid	treatments,	as	demonstrated	through	qPCR.	Staining	of	retinoid-treated	corneas	with	anti-CYP26A1	antibody	revealed	no	obvious	information	as	to	whether	any	of	the	3	cell	layers	in	particular	were	more	highly	responsive	to	retinoid	treatments	than	the	others	(data	not	shown).				 Hyatt	and	colleagues	(1996a)		prevented	the	proper	development	of	photoreceptor	cells	in	zebrafish	in	vivo	with	the	administration	of	just	3µM	Citral.	In	our	experiments,	as	much	as	60µM	of	Citral	had	no	effect	on	lens	regeneration	in	vitro.	It	should	be	noted	however	that	qPCR	data	indicated	that	no	decrease	occurred	in	the	expression	levels	of	cyp26a1	following	Citral	treatment,	suggesting	the	possibility	that	RA	signaling	may	not	have	been	affected	by	that	treatment.	Citral	is	a	competitive	inhibitor	of	the	dehydrogenase	enzymes	responsible	for	RA	synthesis,	and	there	may	have	been	enough	RA	present	in	the	serum	used	in	the	culture	media	to	compensate	for	the	presence	of	Citral.	The	usage	of	LE-135	offers	a	
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better	demonstration	that	inhibition	of	RA	signaling,	specifically	antagonism	of	RARα	and	RARβ,	has	no	consequences	upon	lens	regeneration.	cyp26a1	is	strongly	downregulated	upon	treatment	with	LE-135,	indicating	that	RA	signaling	has	been	negatively	affected.	These	results	stand	in	contrast	to	what	has	been	shown	in	Wolffian	regeneration.	Liarozole	is	a	well-established	inhibitor	of	RA	metabolism	(Pignatello	et	al.,	2002;	Stoppie	et	al.,	2000;	Takeuchi	et	al.,	2011),	and	is	used	clinically	for	the	treatment	of	skin	diseases	(Pavez	Loriè	et	al.,	2009).	Liarozole	treatments	profoundly	inhibited	lens	regeneration,	but	our	results	do	not	distinguish	whether	CYP26	acts	strictly	to	clear	RA	from	the	cornea,	or	if	it	is	necessary	to	generate	RA	metabolites	such	as	4-oxo-RA.	4-oxo-RA	is	known	to	affect	anterior-posterior	(AP)	axis	development	in	Xenopus	(Pijnappel	et	al.,	1993),	but	little	else	is	understood	about	the	potential	signaling	role	for	this	molecule	in	other	contexts.	To	corroborate	the	hypothesis	that	Liarozole	inhibited	regeneration	due	to	increased	RA	signaling	that	results	from	the	raising	of	endogenous	RA	levels,	we	also	treated	eyes	with	TTNPB	and	all-trans	RA,	and	saw	the	same	effect.	TTNPB	has	been	documented	as	a	significantly	more	potent	retinoid	than	all-trans	RA,	and	is	resistant	to	metabolism	by	CYP26	(Kistler	et	al.,	1990;	Pignatello	et	al.,	1997,	1999).	Although	TTNPB	effectively	inhibited	lens	regeneration,	we	did	not	observe	a	significantly	greater	inhibition	of	regeneration	with	the	use	of	TTNPB	compared	to	all-trans	RA.	cyp26a1	expression	as	examined	by	qPCR	also	did	not	show	a	significant	increase	of	potency	for	TTNPB	over	RA.	Treatments	with	retinoids	such	as	TTNPB	are	known	to	cause	AP	axis	defects	during	Xenopus	development	(Minucci	et	al.,	1996).	We	treated	Xenopus	gastrulas	with	the	same	concentrations	of	retinoids	used	in	the	lens	regeneration	assays	to	observe	axis	defects,	and	again	found	that	TTNPB	was	not	more	potent	than	RA	for	inducing	defects	(data	not	shown).	Therefore,	although	the	reason	for	the	lack	of	increased	potency	of	TTNPB	over	all-trans	RA	in	our	experiments	is	unclear,	it	is	not	likely	that	it	is	due	to	a	unique	functional	difference	of	TTNPB	in	the	context	of	cornea-lens	regeneration.				 Treatment	with	1µM	RA	did	not	have	an	effect	on	lens	regeneration,	even	though	it	greatly	stimulated	the	expression	of	cyp26a1,	and	20µM	of	RA	both	
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completely	inhibited	lens	regeneration	and	stimulated	cyp26a1	expression.	This	data	suggests	that	there	is	a	limit	to	the	RA-protective	activity	of	CYP26	within	these	tissues.	cyp26a1	expression	is	simply	an	indicator	of	changes	in	RA	signaling	activity	and	the	data	shows	that	its	expression	is	not	by	itself	the	cause	of	the	inhibition	of	lens	regeneration.		 Cell	proliferation	occurs	throughout	the	larval	cornea	epithelium	(Perry	et	al.,	2013).	Retinoic	acid	is	an	inducer	of	epithelial	cell	proliferation	(Kim	et	al.,	2012;	Nabeyrat	et	al.,	1998;	Wang	et	al.,	1997)	and	its	popularity	in	pharmaceutical	applications	(as	Tretinoin)	is	partly	derived	from	this	property.	Although	it	is	not	yet	clear	whether	the	regenerated	lens	in	Xenopus	is	derived	from	transdifferentiated	cornea	cells,	or	multipotent	cornea	stem	cells,	a	final	phase	of	cellular	differentiation	is	clearly	necessary	in	the	course	of	generating	a	new	lens	de	
novo.	We	assessed	whether	the	presence	of	RA	in	corneal	tissue	may	prevent	proper	differentiation	of	cells	due	to	changes	cell	proliferation.	We	cultured	normal,	whole	corneas	in	vitro	in	the	presence	of	Liarozole	or	retinoids,	and	examined	cell	division	through	immunohistochemical	staining	of	phosphorylated	Histone	H3.	Although	our	examination	was	confined	to	a	single	snapshot	in	time,	we	can	nonetheless	observe	the	effects	of	these	compounds	on	cell	proliferation	in	control	and	drug-treated	corneal	tissue.	Interestingly,	CYP26	inhibition	via	Liarozole	reduced	cell	proliferation	in	half,	but	treatment	with	the	retinoids	did	not	have	any	measurable	effect	on	proliferation	(Fig.	2.4F).	This	suggests	that	the	inhibitory	effect	of	Liarozole	on	cell	division	is	not	likely	due	to	rising	levels	of	endogenous	RA	levels	in	these	tissues.	Rather,	it	is	possible	that	the	metabolite	generated	by	CYP26,	4-oxo-RA,	may	be	a	regulator	of	cell	division	in	the	cornea.	The	action	of	CYP26	therefore	may	be	necessary	as	a	regulator	of	cell	turnover,	and	by	extension,	an	enabler	of	proper	differentiation	into	lens	cells.	It	additionally	seems	that	the	inhibitory	effect	of	exogenous	retinoids	on	lens	regeneration	is	not	caused	by	depressed	(or	elevated)	cellular	division.	This	leaves	open	the	possibility	that	although	decreased	cell	division	is	coincident	with	Liarozole	treatment,	it	may	not	itself	be	the	cause	of	inhibited	lens	regeneration.	In	fact,	inhibiting	cell	proliferation	in	the	Xenopus	
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cornea	with	Mitomycin	C	does	not	inhibit	lens	regeneration	(Filoni	et	al.,	1995).	Further	experiments	are	necessary	to	definitively	confirm	the	mechanistic	roles	and	cytological	consequences	of	CYP26	action,	and	excess	retinoids,	during	lens	regeneration.		We	have	recently	provided	evidence	for	a	possible	stem	cell	identity	for	cells	of	the	basal	and	fibrillar	layers	(Perry	et	al.,	2013),	and	CYP26	may	act	to	prevent	the	differentiating	effects	of	RA	in	order	to	maintain	cellular	multipotency.	We	tested	this	possibility	by	treating	corneas	with	drugs	in	vitro,	to	observe	how	it	might	affect	the	expression	of	sox2,	oct60,	and	p63,	three	putative	stem	cell	markers	expressed	within	the	cornea	that	are	upregulated	in	the	early	stages	of	lens	regeneration.	Most	notably,	CYP26	antagonism	during	tissue	culture	did	not	affect	the	expression	of	any	of	these	markers	(Fig.	2.5),	even	though	the	antagonism	was	shown	to	strongly	inhibit	lens	regeneration	(Fig.	2.2A).	Interestingly,	the	presence	of	1µM	RA	affected	the	expression	of	all	3	genes	(Fig.	2.5),	although	it	does	not	affect	lens	regeneration	(Fig.	2.2C).	Taken	together,	it	appears	that	altering	the	expression	levels	of	these	particular	genes	(to	the	modest	degrees	seen	in	our	experiments)	is	not	related	to	lens	regenerating	competence	in	the	tissue.	Notably,	this	does	not	provide	evidence	that	the	resident	stem	cell	population	is	irrelevant	for	lens	regeneration.	Indeed,	the	cornea	is	composed	of	a	heterogeneous	cell	population,	and	SOX2	and	P63	localize	to	different	subpopulations	of	cells	(Perry	et	al.,	2013).	Since	it	is	not	yet	known	which	cells	are	important	for	lens	regeneration	and	which	are	important	for	corneal	maintenance	and	repair,	it	remains	unclear	whether	and	how	CYP26	relates	to	cellular	multipotency	or	lens	regenerating	competence	of	the	cornea.	It	should	be	noted	that	it	is	not	possible	to	reliably	isolate	regenerating	corneal	tissue	once	it	is	inserted	into	the	eyecup	and	cultured	in	vitro.	Therefore,	we	were	unable	to	evaluate	how	the	expression	of	these	genes	might	be	affected	following	lens	removal,	where	the	cornea	is	exposed	to	signaling	factors	from	the	retina,	in	addition	to	the	pharmacological	compounds	used	in	this	study.	Regardless,	it	can	be	inferred	from	our	data	that	whatever	role	RA	regulation	plays	
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to	support	cornea-lens	regeneration,	it	is	not	likely	via	the	modulation	of	sox2,	oct60,	and	p63	transcription.			 Considerable	effort	has	been	invested	into	understanding	the	retinal	factors	that	initiate	the	process	of	lens	regeneration	in	vertebrates,	and	FGF	and	FGFRs	have	emerged	as	important	targets	of	study	(Bosco	et	al.,	1997;	Fukui	and	Henry,	2011).	However,	the	nature	of	the	cornea	that	makes	it	competent	to	respond	to	those	retinal	signals	is	poorly	understood.	pax6	expression	is	one	factor	that	has	been	associated	with	lens	regeneration	competence	(Gargioli	et	al.,	2008).	We	presently	provide	evidence	that	RA	signaling	must	be	attenuated	within	the	cornea	epithelium,	which	could	in	part	be	responsible	for	endowing	this	tissue	with	lens-forming	competence.	Additionally	the	present	study	presents	for	the	first	time	a	role	for	CYP26	in	regeneration.	It	highlights	an	important	deviation	from	Wolffian	lens	regeneration,	and	presents	a	contrasting	view	to	the	regeneration-enabling	role	historically	attributed	to	retinoic	acid	(Maden	and	Hind,	2003).	The	clear	differences	between	Wolffian	and	Xenopus	regenerative	processes,	as	demonstrated	here,	underscore	the	importance	of	investigating	animal	specific	variations	in	regeneration	of	the	same	tissues,	and	may	reveal	mechanisms	that	limit	regenerative	phenomena.																			
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Figure	2.1	
	
			
Expression	of	RA	signaling	related	genes.	
	(A)	Expression	of	RA-signaling	related	genes	in	control	corneas	(C)	and	pooled	regenerating	corneas	from	1,	3,	and	5	days	post-lentectomy	(R).	“+RT”	group	indicates	reactions	that	employed	reverse	transcriptase	for	generation	of	cDNA.	“–RT”	group	indicates	reactions	that	used	water	in	place	of	reverse	transcriptase,	as	a	control	for	genomic	contamination.	“+”	indicates	a	positive	control	reaction	performed	using	embryonic	RNA	(B)	Expression	of	genes	in	control	lenses.															
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Figure	2.2	
	
	
RA	signaling	inhibits	lens	regeneration,	and	RA	signaling	antagonism	does	not	inhibit	
lens	regeneration.	
	(A)	Liarozole	and	TTNPB	are	potent	inhibitors	of	cornea-lens	regeneration.	A	high	concentration	of	RA	very	strongly	inhibits	lens	regeneration.	*	indicates	p<	0.0001,	using	two-tailed	Fischer’s	exact	test.	(B)	A	drug-treatment	validation	assay	using	qPCR	shows	that	all	of	the	drugs	strongly	activate	RA	signaling,	as	seen	by	a	profound	upregulation	of	cyp26a1,	a	marker	of	active	RA	signaling,	in	the	cornea.	*	indicates	p<0.01,	using	unpaired	t	test.	(C)	Citral	and	LE-135,	inhibitors	of	RA	signaling,	fail	to	inhibit	cornea-lens	regeneration.	(D)	A	drug-treatment	validation	assay	using	qPCR	shows	that	LE-135	attenuates	expression	of	cyp26a1	in	the	cornea.	*	indicates	p	<0.0001,	using	unpaired	t	test.	All	error	bars	indicate	standard	error.	
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Figure	2.3	
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Figure	2.3	(cont.)	
	
Lens	regeneration	assays.	
	Representative	examples	are	shown	of	positive	cases	of	lens	regeneration	for	each	condition	tested,	with	the	exception	of	20µM	RA,	for	which	no	lenses	regenerated.	Panels	A,	E,	I,	M,	Q,	U,	C,	G,	K,	Q,	S,	and	W	are	images	taken	with	a	DIC	microscope.	Panels	B,	F,	J,	N,	R,	V,	D,	H,	L,	P,	T,	and	X	are	images	of	fluorescently	labeled	lenses	with	an	anti-lens	antibody	(Red).	Arrowheads	indicate	the	regenerated	lens.	Scale	bar	in	X=	100µm																																		
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Figure	2.4		
			
The	effect	of	CYP26	inhibition,	and	exogenous	retinoids	on	cell	proliferation	in	the	
cornea.	
	Nuclei	are	labeled	with	Hoechst	(blue)	and	mitotic	cells	are	labeled	with	anti-phospho-Histone	H3	antibody	(green).	When	compared	to	treatment	with	DMSO	in	vitro	(A),	treatment	with	TTNPB	(C),	1µM	RA	(D),	or	20µM	RA	(E)	has	no	effect	on	the	number	of	mitotic	cells	at	in	the	cornea.	Treatment	with	Liarozole	(B)	reduced	cell	division.	White	arrowheads	indicate	examples	of	mitotic	figures	found	in	the	cornea.	Note	that	not	every	mitotic	figure	is	pointed	out	in	(A)	and	(E).	The	white	dotted	outline	demarcates	the	cornea	proper	from	pericorneal	epithelium.	The	results	are	quantified	in	(F).	Error	bars	show	standard	error.	*	indicates	p<0.0001	using	unpaired	t-test.	Scale	bar	in	E=	50µm			
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Figure	2.5			 		
qPCR	of	putative	corneal	stem	cell	markers.	
	Corneas	cultured	in	vitro	in	the	presence	of	retinoids	show	upregulation	of	sox2,	and	downregulation	of	oct60	and	p63.	CYP26	inhibition	with	Liarozole	does	not	affect	the	expression	of	any	of	these	genes.	Error	bars	show	standard	error.	*	indicates	
p<0.05	and	**	indicates	p<	0.001	using	unpaired	t-test.															
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Figure	2.6			
		
Cellular	localization	of	CYP26	and	RALDH	enzymes	in	the	cornea.	
	Corneal	whole-mount	immunofluorescence	staining	was	used	to	visualize	the	expression	of	CYP26A	(A-C),	CYP26B	(D-F),	and	RALDH1	(G-I),	in	each	of	the	3	layers	of	the	larval	cornea—	the	outer	epithelium	(A,	D,	G),	the	basal	layer	(B,	E,	H),	and	the	deeper	fibrillar	layer	(C,	F,	I).	CYP26A	(green)	is	expressed	in	all	layers,	including	the	sparse	cells	of	the	fibrillar	layer	(arrowheads).	CYP26B	(green)	and	RALDH1	(green)	are	only	expressed	in	the	outer	epithelial	and	basal	layers,	and	are	not	seen	in	the	cells	of	the	fibrillar	layer	(arrowheads).	DAPI	(blue),	phalloidin	(red).	Scale	bar	in	G	=	20µm	
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Supplemental	Table	1		 																																											
Primer	Name	 Sequence	(5’->3’)	 TM	(ºC)	 Product		
size	(bp)	qpcr_actb_forward	 CGCCCGCATAGAAAGGAGAC	 60	 128	qpcr_actb_reverse	 AGCATCATCCCCAGCAAAGC	qpcr_cyp26a1_forward	 GGCTGTCTGTCCAACCTGC	 60	 181	qpcr_cyp26a1_reverse	 GTCGCTTGATGGCGGGATAC	qpcr_sox2_forward	 CCCCGGGCATGTCTCTGGGA	 60	 195	qpcr_sox2_reverse	 GTTGCGACATGTGCAGTCTGCTTTGC	qpcr_oct60_forward	 CAGAAACACAGCCGGACAGA	 60	 66	qpcr_oct60_reverse	 CACCCATAGCAGCACAGCAT	qpcr_p63_forward	 ACAGTGTCACCGCACCATCACC	 60	 158	qpcr_p63_reverse	 CGTCCAGGTGGCTGACTTTGC	cyp26a1_forward	 GGCACTGAAAGAATCCGCAA	 50	 406	cyp26a1_reverse	 CGGCGTTAGAAATCGGTCTG	cyp26b1_forward	 TCCCCAAAGGTTGGAGTGTT	 53	 244	cyp26b1_reverse	 GCAAGCTCAAACCTGCTCAT	cyp26c1_forward	 TACCAGATCCCCAAAGGCTG	 53	 238	cyp26c1_reverse	 TGGCAGTAGTTACCAGCTCC	aldh1a1_forward	 GTGGAAAGAAAGAAGGCGCA	 50	 377	aldh1a1_reverse	 TTCATGCAGGCCATATTCGC	aldh1a2_forward	 TGCCAGCGTTCAGTAGAAAC	 50	 410	aldh1a2_reverse	 GGAAGCACAATACAAGGCGA	aldh1a3_forward	 ATGCCCTGCATACACAGACT	 53	 420	aldh1a3_reverse	 TGTGACAATGGCAATCACGG	gapdh_forward	 CTTGAAGGGAGGTGCCAAGC	 50	 491	gapdh_reverse	 CCAGGATTCCCTTCATTGGGC	
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CHAPTER	3		
Understanding	the	basis	of	CYP26	mediated	regulation	of	lens	regeneration		 The	ability	to	fully	regenerate	a	lost	lens	is	a	unique	phenomenon	amongst	some	animals.	No	mammal	has	been	identified	with	this	ability,	but	several	vertebrates	including	salamanders	and	frogs	have	been	studied	for	years	for	their	ability	to	regenerate	a	lens	de	novo	(Freeman,	1963;	Henry,	2003).	In	the	frog	
Xenopus	laevis,	regeneration	begins	following	the	removal	of	the	lens	from	tadpole	larvae.	In	the	absence	of	the	lens	and	the	inner	cornea	endothelium,	molecular	factors	from	the	retina	cross	the	vitreous	chamber	and	reach	the	cornea	epithelium	(“cornea”),	which	triggers	morphological	and	cytological	changes,	and	the	cornea	gives	rise	to	a	new	lens	within	a	matter	of	days.	Not	all	of	the	retinal	and	corneal	factors	responsible	for	this	phenomenon	have	been	identified,	but	Fibroblast	Growth	Factors	(FGFs)	from	the	retina	have	been	implicated	as	a	necessary	and	sufficient	trigger	for	lens	regeneration	in	Xenopus	(Bosco	et	al.,	1997;	Fukui	and	Henry,	2011).	Our	understanding	of	what	makes	the	cornea,	and	not	any	other	surrounding	ectoderm,	capable	of	responding	to	these	signals	is	much	less	clear.			 Retinoic	acid	signaling	is	known	to	govern	the	proper	morphogenesis	of	the	eye,	including	the	development	of	the	retina,	lens,	and	cornea	(Enwright	and	Grainger,	2000;	Kastner	et	al.,	1994;	Molotkov	et	al.,	2006;	Wagner	et	al.,	2000).	It	is	mediated	through	the	ligand	all-trans	Retinoic	Acid	(RA),	derived	from	Vitamin	A,	which	binds	to	RA	receptors	in	the	nucleus	to	modulate	transcription.	RA	signaling	can	be	regulated	both	at	the	level	of	its	synthesis	by	RALDH	enzymes,	or	metabolism	by	CYP26,	among	other	means	(reviewed	by	Bastien	and	Rochette-Egly,	2004).	RA	is	also	involved	within	the	cornea	to	enable	lens	regeneration.	It	is	required	for	lens	regeneration	in	newts,	as	demonstrated	when	antagonism	of	RA	signaling	receptors	using	pharmacological	inhibitors	diminished	regeneration	(Tsonis	et	al.,	2000;	Tsonis	et	al.,	2002).	In	newts,	the	lens	regenerates	from	the	dorsal	iris	exclusively,	instead	of	the	cornea.	The	ventral	iris	can	be	converted	into	a	tissue	capable	of	
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generating	lens	cells	if	it	is	made	to	express	six3	in	the	presence	of	exogenous	RA	(Grogg	et	al.,	2005).	We	have	demonstrated	that	lens	regeneration	in	Xenopus	is	notably	different	with	regards	to	RA	signaling.	Antagonism	of	RA	signaling	has	no	effect	on	lens	regeneration	in	Xenopus,	and	in	fact	the	activity	of	the	RA-metabolizing,	cytochrome	P450	enzyme	CYP26	is	necessary	to	support	regeneration.	Two	orthologs,	CYP26A	and	CYP26B	are	both	expressed	in	the	cornea,	and	their	antagonism	using	the	molecule	Liarozole	inhibits	lens	regeneration	just	like	the	addition	of	excess	exogenous	RA,	or	an	RA	analog	that	cannot	be	metabolized	(Thomas	and	Henry,	2014).	In	developing	Xenopus	embryos,	CYP26	is	expressed	in	the	lens	epithelium,	further	supporting	the	need	for	CYP26	activity	in	the	course	of	generating	a	lens	(Hollemann	et	al.,	1998).	The	key	question	remains	however	of	whether	CYP26	acts	in	the	cornea	exclusively	to	clear	RA	from	the	cells	to	attenuate	RA	signaling,	or	whether	CYP26	additionally	acts	to	actively	generate	retinoid	metabolites,	such	as	4-oxo-RA,	which	may	be	required	for	signaling.	This	scenario	is	further	supported	by	the	observation	that	CYP26	antagonism	via	Liarozole	inhibits	cell	division	in	the	outer	cornea	epithelium,	but	excess	exogenous	RA	and	RA	analogs	do	not.	Notably,	a	suspension	of	cell	division	does	not	by	itself	inhibit	lens	regeneration	in	Xenopus	(Filoni	et	al.,	1995),	but	the	observation	suggests	that	RA	itself	does	not	regulate	cell	division	despite	the	important	role	of	CYP26.	Although	our	work	has	implicated	CYP26	in	regeneration,	antagonism	of	CYP26	by	itself	cannot	parse	the	difference	between	whether	CYP26	is	necessary	for	the	tissue	to	be	depleted	of	RA,	or	if	it	is	also	needed	to	create	RA	metabolites	that	participate	in	signaling	events	that	permit	regeneration.	This	led	to	the	hypothesis	that	CYP26	acts	to	generate	an	important	metabolite	like	4-oxo-RA	for	cell	division	and	lens	regeneration.	Moreover,	the	time	period	during	which	CYP26	activity	was	necessary	for	lens	regeneration	was	previously	undetermined.	Our	hypothesis	is	that	CYP26	activity	is	required	early	during	lens	regeneration	as	a	factor	regulating	the	initial	competence	to	regenerate	a	lens.		 CYP26	eliminates	the	availability	of	RA	for	signaling	by	metabolizing	it,	primarily	to	4-oxo-RA	and	4-OH-RA	(White	et	al.,	1996),	of	which	4-oxo-RA	is	longer	
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lived	(Topletz	et	al.,	2012).The	action	of	CYP26	is	often	coordinated	with	RA	synthesis	in	order	to	restrict	RA	signaling	within	specific	tissue	boundaries	(Duester,	2008;	Rhinn	and	Dolle,	2012).	Other	potential	RA	metabolites,	like	4-OH-RA,	are	known	to	exhibit	biological	activity	in	cells	(Idres	et	al.,	2002;	Reynolds	et	al.,	1993),	but	the	roles	of	these	other	metabolites	are	not	well	established,	especially	in	developmental	and	in	vivo	contexts.	We	presently	focus	on	4-oxo-RA,	which	is	known	to	affect	Xenopus	development	(Pijnappel	et	al.,	1993).	There	is	little	additional	data	regarding	whether	4-oxo-RA	is	a	biologically	relevant	signaling	molecule,	and	there	is	no	consensus	amongst	the	few	studies	in	which	it	has	been	examined	(Niederreither	et	al.,	2002;	Pijnappel	et	al.,	1993).			 We	performed	lens	regeneration	assays	using	an	ex	vivo	eye	culture	system	to	assess	the	effects	of	4-oxo-RA	supplementation	on	regeneration.	The	ex	vivo	lens	regeneration	assays	were	performed	as	previously	detailed	in		Fukui	and	Henry,	2011,	and	Thomas	and	Henry,	2014,	with	some	modifications.	Animals	staged	48-53	(all	staging	in	this	study	are	according	to	Niewkoop	and	Faber,	1956)	were	used	throughout	the	experiments,	and	they	were	anesthetized	in	1:2000	MS-222	(Sigma,	St.	Louis,	MO)	diluted	in	1/20	NAM	(normal	amphibian	media),	where	they	remained	for	the	duration	of	lens	removal	surgery	(lentectomy).	Using	fine	scissors,	the	outer	cornea	is	cut	and	the	lens	is	removed	through	the	incision	before	the	whole	eye	is	excised	from	the	head	and	placed	into	a	well	of	a	24-well	culture	plate.	Eyes	are	individually	cultured	in	350µL	of	“modified	L-15	media”	(2:3	dilution	of	L-15	media,	with	10%	fetal	bovine	serum)	for	7	days.	The	media	was	also	supplemented	with	the	appropriate	amount	of	pharmacological	compound	or	the	vehicle	DMSO	(Fisher	Scientific,	Fair	Lawn,	NJ),	in	the	same	amounts	as	reported	in	previous	work	(Thomas	and	Henry,	2014).	The	compounds	used	are:	100µM	Liarozole	hydrochloride	(Tocris,	Bristol,	UK),	20µM	all-trans	Retinoic	Acid	(Sigma),	and	20µM	4-oxo-Retinoic	Acid	(TRC,	Toronto,	Canada).	The	concentration	of	4-oxo-RA	was	chosen	to	be	sufficiently	high	to	elicit	a	physiological	response	in	ex	vivo	culture.	Culture	media	was	changed	every	other	day,	and	after	7	days	of	culture,	the	eyes	were	rinsed	in	PBS	and	then	fixed	in	3.7%	formaldehyde	(Sigma)	for	1	hour	at	
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25ºC.	Then	the	eyes	were	then	embedded	in	paraffin	wax	for	sectioning	at	a	thickness	of	10µm,	and	placed	onto	a	positively	charged	slide	(Colorfrost	Plus,	Thermo	Scientific,	Kalamazoo,	MI)	before	immunohistochemical	staining	with	a	rabbit	polyclonal	anti-lens	antibody	(Henry	and	Grainger,	1990).	The	sections	were	examined,	and	the	presence	of	a	morphologically	distinct	lentoid	structure	that	positively	stained	with	the	anti-lens	antibody	was	scored	as	a	positive	case	of	lens	regeneration.	Statistical	significance	in	differences	between	regeneration	rates	was	established	using	(two-tailed)	Fisher’s	Exact	test.			 Of	DMSO	treated	eyes,	11/13	(85%)	regenerated	lenses.	When	eyes	were	treated	with	the	CYP26	inhibitor	Liarozole,	only	2/13	(15%)	eyes	regenerated	lenses,	showing	greatly	diminished	regeneration	(p=0.0012),	as	we	expected	and	previously	reported	(Thomas	and	Henry,	2014).	In	order	to	determine	whether	CYP26	is	relevant	simply	as	an	ablator	of	RA	within	the	corneal	tissue,	or	if	it	is	also	an	important	generator	of	the	RA	metabolite	4-oxo-RA	to	act	as	a	novel	signaling	ligand	in	regeneration,	we	assessed	whether	lens	regeneration	could	be	rescued	in	cultures	co-treated	with	Liarozole	and	4-oxo-RA.	The	exogenous	addition	of	20µM	4-oxo-RA	alone	resulted	in	only	a	minor	reduction	in	regeneration	(p=	0.046)	as	7/14	(50%)	regenerated	lenses.	The	addition	of	4-oxo-RA	and	Liarozole	together	did	not	significantly	increase	the	rate	of	regeneration	compared	to	Liarozole	alone,	and	the	rate	was	still	significantly	lower	(2/21,	9.5%;	p	<0.0001)	than	DMSO	treated	eyes	(Figure	3.1A).	No	obvious	size	differences	were	noted	amongst	any	regenerated	lenses.	If	it	were	the	case	that	CYP26	antagonism	was	inhibiting	lens	regeneration	due	to	diminished	4-oxo-RA	production	in	the	cornea,	then	the	addition	of	exogenous	4-oxo-RA	should	have	compensated	for	the	loss	and	rescued	regeneration.	However,	our	result	shows	that	this	is	not	the	case,	providing	evidence	that	4-oxo-RA	is	not	a	relevant	signaling	molecule	in	the	context	of	lens	regeneration.	Note	that	this	does	not	rule	out	the	possibility	that	other	retinoid	metabolites,	such	as	4-OH-RA,	could	be	involved	in	regeneration.		
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To	assess	whether	the	addition	of	4-oxo-RA	to	our	cultures	has	any	molecular	effect	on	the	tissues,	we	cultured	excised	eyes	in	the	presence	of	4-oxo-RA,	harvested	the	corneas	4	days	later,	and	then	extracted	RNA	to	perform	qPCR,	using	previously	reported	methods	(Thomas	and	Henry,	2014).	We	specifically	examined	the	expression	changes	of	the	gene	cyp26a1,	which	encodes	CYP26	and	is	a	key	positive	marker	that	indicates	active	RA-signaling	(de	Roos	et	al.,	1999;	Hollemann	et	al.,	1998;	Pavez	Loriè	et	al.,	2009).	Notably,	the	act	of	cyp26a1	upregulation	itself	has	no	impact	on	the	rate	of	lens	regeneration,	it	is	simply	used	as	a	molecular	marker	to	determine	whether	RA	signaling	is	active	or	not	(Thomas	and	Henry,	2014).	RNA	was	extracted	from	corneas	that	were	cultured	with	DMSO	or	20µM	4-oxo-RA	for	4	days.	Each	technical	replicate	within	each	qPCR	experiment	received	20ng	of	input	cDNA.	Fold	changes	of	expression	were	determined	using	the	comparative	CT	method	(Schmittgen	and	Livak,	2008).	For	the	purposes	of	determining	statistical	significance	and	standard	error,	a	single	“N”	was	defined	as	the	whole	experiment	performed	from	start	to	finish,	starting	with	surgical	harvest	of	tissues	from	live	animals,	and	ending	with	a	qPCR	run.	Statistical	significance	was	established	using	the	(unpaired)	t	test.			 We	observed	that	treatment	with	4-oxo-RA	profoundly	upregulated	the	expression	of	cyp26a1	within	the	cornea	(N=3;	p<0.01)	(Figure	3.1B),	demonstrating	that	within	our	ex	vivo	culture	system	4-oxo-RA	can	and	does	act	as	a	signaling	ligand	that	effects	transcriptional	events	within	the	corneal	tissue.	It	likely	does	so	through	the	nuclear	retinoic	acid	receptor	RARβ,	as	it	has	been	shown	to	have	a	high	affinity	for	that	receptor	(Pijnappel	et	al.,	1993).	The	upregulation	of	the	cyp26a1	gene	is	indicative	of	elevated	RA	signaling,	and	this	elevation	could	be	the	reason	for	the	mild	reduction	in	regeneration	observed	with	4-oxo-RA	treatment	alone.	Note	however	that	it	is	not	obvious	from	our	experiment	whether	physiologic	levels	of	4-oxo-RA	generated	by	endogenous	corneal	CYP26	can	evoke	such	transcriptional	changes.	To	further	validate	the	activity	of	the	4-oxo-RA	used	in	experiments,	we	treated	stage	10	Xenopus	gastrulas	with	20µM	4-oxo-RA	for	about	48	hours	and	observed	them	at	stage	29.	Compared	to	DMSO-treated	gastrulas,	all	
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embryos	exhibited	severe	defects	of	the	anterior-posterior	axis	(Figure	3.1H),	indicating	abnormal	RA	signaling	within	the	developing	embryo,	just	as	described	by	Pijnappel	et	al.	(1993).	Altogether,	we	have	shown	that	exogenous	4-oxo-RA	can	elicit	a	molecular	response,	but	whatever	the	function	of	CYP26	is	within	the	cornea,	it	does	not	appear	to	act	as	a	generator	of	4-oxo-RA	to	enable	lens	regeneration.		 Earlier	work	has	demonstrated	that	CYP26	antagonism	via	Liarozole	leads	to	diminished	cell	proliferation	in	the	cornea.	However	this	effect	of	Liarozole	is	not	the	cause—or	is	at	least	not	necessary—for	inhibited	lens	regeneration	from	the	cornea	because	concentrations	of	RA	that	also	inhibit	lens	regeneration	fail	to	impact	cell	proliferation	(Thomas	and	Henry,	2014),	despite	the	fact	that	RA	generally	acts	to	promote	epithelial	cell	turnover	(Nabeyrat	et	al.,	1998;	Wang	et	al.,	1997).	Thus,	even	though	CYP26	is	important	for	regulating	cell	division	in	the	cornea,	we	hypothesized	that	it	must	be	doing	so	in	an	RA-independent	manner.	Given	these	observations,	we	examined	whether	cell	proliferation	is	reduced	in	the	cornea	due	to	the	failure	to	generate	the	metabolite	4-oxo-RA	upon	CYP26	antagonism.			 Eyes	were	excised	from	stage	49-51	animals,	and	cultured	with	attached	corneas	in	media	supplemented	with	the	appropriate	pharmacological	compound	or	DMSO,	just	as	in	the	qPCR	experiments.	After	4	days	of	culture,	explanted	eyes	were	rinsed	with	PBS	and	fixed	in	3.7%	formaldehyde	for	1	hour	at	25ºC.	The	explants	were	stained	for	phospho-Histone	H3,	a	marker	of	dividing	cells	(Hans	and	Dimitrov,	2001),	using	a	rabbit	anti-phospho-Histone	H3	antibody	(provided	by	Dr.	Craig	Mizzen,	University	of	Illinois	at	Urbana-Champaign).	Nuclei	were	visualized	by	staining	with	1:10,000	Hoechst	(Molecular	Probes,	Eugene,	OR)	for	20	minutes.	After	staining,	the	corneas	were	carefully	detached	from	the	eyes	and	placed	into	a	drop	of	Prolong	Gold	mounting	media	(Invitrogen)	on	a	glass	microscope	slide.	A	coverslip	was	then	placed	atop	the	tissue	that	was	then	pressed	flat	before	observation	under	a	Zeiss	Axioplan	microscope.	Each	cornea	was	photographed	and	the	images	were	used	to	quantify	cell	division.	In	order	to	quantify	cell	division,	a	
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standard	square	area	was	selected	within	each	image	to	determine	the	nuclear	density	of	that	cornea.	The	total	number	of	nuclei	in	each	cornea	was	calculated	by	multiplying	the	nuclear	density	by	the	total	area	of	that	cornea	determined	using	ImageJ	(U.S.	National	Institutes	of	Health,	Bethesda,	MD).	The	total	number	of	mitotic	figures	in	each	cornea	was	counted	manually,	and	the	number	of	mitotic	figures	per	100	nuclei	(MFN)	was	used	as	measure	of	cell	division.	For	the	purposes	of	determining	statistical	significance	and	standard	error,	each	“N”	is	defined	as	an	individual	cornea	on	which	the	above	analysis	was	performed.	When	pericorneal	tissue	was	present	in	each	image,	it	was	excluded	from	analysis.	Statistical	significance	was	determined	using	the	(unpaired)	t	test.		 The	cell	division	assay	was	performed	in	the	presence	of	DMSO,	100µM	Liarozole,	20µM	4-oxo-RA,	or	both	Liarozole	and	4-oxo-RA	(Figure	3.1	C-G).	Liarozole	treatment	in	our	experiments	diminished	the	MFN	by	nearly	half	(mean	MFN=0.77;	N=10;	p=	0.0159)	compared	to	DMSO-treated	corneas	(mean	MFN=1.34;	N=12).	Treatment	with	4-oxo-RA	alone	had	no	significant	effect	on	proliferation	(mean	MFN=	1.46;	N=14).	Treatment	with	both	Liarozole	and	4-oxo-RA	had	the	same	inhibitory	effect	on	cell	proliferation	as	Liarozole	treatment	alone	had	(mean	MFN	=	0.44;	N=14;	p	=	0.0002).	As	the	addition	of	4-oxo-RA	with	Liarozole	could	not	recover	the	MFN	to	control	levels,	it	shows	that	the	inhibition	of	cell	proliferation	observed	with	CYP26	antagonism	is	not	explained	by	diminished	4-oxo-RA	production.	While	proliferating	cells	in	the	cornea	do	contribute	to	the	regenerating	lens	following	lens	removal	(Perry	et	al.,	2013),	a	complete	arrest	of	cell	division	using	Mitomycin	C	reportedly	does	not	stop	lens	regeneration	(Filoni	et	al.,	1995).	The	exact	reason	for	the	effects	that	Liarozole	have	is	unclear,	and	work	remains	to	be	done	to	understand	the	exact	relationships	between	retinoic	acid	signaling,	CYP26	activity,	corneal	cell	proliferation,	and	lens	regeneration.		 Next	we	determined	when	during	regeneration	CYP26	is	important,	as	it	has	remained	unclear	whether	CYP26	activity	is	relevant	during	earlier,	later,	or	all	stages	of	lens	regeneration.	Earlier	work	had	left	open	the	possibility	that	CYP26	
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activity	could	be	important	in	order	to	maintain	a	lentogenic	bias	in	the	cornea	when	the	cornea	tissue	first	responds	to	retinal	factors	(Thomas	and	Henry,	2014).	It	may	additionally	or	instead	be	needed	during	later	stages	of	regeneration,	such	as	during	morphogenesis	and	growth	of	the	regenerated	lens,	or	differentiation	of	lens	fiber	cells	and	crystallin	expression.	We	tested	the	timing	of	CYP26	relevance	during	lens	regeneration	by	varying	the	timepoints	at	which	the	CYP26	inhibitor	Liarozole,	or	RA	was	added	(Figure	2A).	We	first	setup	our	controls	by	reproducing	earlier	work	to	show	that	lens	regeneration	in	ex	vivo	culture	is	inhibited	by	both	Liarozole	(3/20,	15%;	p=0.0063)	and	RA	(1/26,	4%;	p<0.0001)	when	compared	to	DMSO	(16/28,	58%)	(Figure	3.2B).	In	these	controls,	the	compounds	are	added	to	the	culture	media	immediately	after	lens	removal,	and	the	tissues	are	exposed	to	them	throughout	7	days	of	regeneration.		 We	simultaneously	performed	2	other	experiments,	where	the	addition	of	the	compounds	were	delayed	by	either	12	or	48	hours	following	lentectomy	(Figure	2B)	to	examine	the	effects	on	regeneration.	The	results	of	a	12-hour	delay	were	similar	to	that	of	the	controls,	as	regeneration	was	reduced	by	both	Liarozole	(4/22,	18%;	p=0.0046)	and	RA	(0/33,	0%;	p<0.0001),	when	compared	to	DMSO	(17/29,	59%).	This	result	demonstrates	that	CYP26	activity	and	RA	signaling	ablation	are	still	necessary	after	the	first	12	hours	that	follow	lens	removal.	However,	when	the	addition	of	the	compounds	was	delayed	by	48	hours,	lens	regeneration	was	unaffected.	Both	Liarozole	(19/22,	86%)	and	RA	(15/19,	79%)	treated	eyes	regenerated	at	nearly	the	same	rate	as	DMSO	treated	ones	(27/34,	79%).	This	result	demonstrates	that	CYP26	activity	and	RA	signaling	ablation	is	not	needed	beyond	the	first	48	hours	of	regeneration.	Taken	together,	it	appears	that	there	is	window	of	time	within	the	first	2	days	of	regeneration	during	which	RA	signaling	attenuation	must	be	maintained.	Past	results	have	shown	interesting	differences	in	the	results	of	Liarozole	and	RA	treatment,	such	as	diminished	cell	division	with	the	former,	but	not	with	the	latter,	and	inhibited	lens	regeneration	with	either.	This	suggested	that	the	although	the	observation	of	inhibited	lens	regeneration	was	common	to	both	treatments,	the	underlying	molecular	mechanism	that	is	disrupted	in	each	case	
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could	be	different,	coincidentally	leading	to	the	same	result.	Given	our	current	finding	that	regeneration	is	sensitive	to	both	elevated	RA	and	CYP26	antagonism	only	in	the	first	12-48	hours	post-lentectomy,	the	disrupted	mechanism	or	mechanisms,	whatever	they	may	be,	are	likely	more	related	than	one	would	think.	For	example,	a	reduced	ratio	of	nucleoli	per	nucleus	is	one	of	the	earliest	indications	of	lens	regeneration	from	the	cornea,	and	is	seen	within	24	hours	post-lentectomy	in	vivo	(Freeman,	1963).	CYP26	activity	and	RA	signaling	attenuation	could	regulate	the	different	steps	that	facilitate	this	histological	event.	Although	there	are	possible	timing	differences	in	ex	vivo	culture	lens	regeneration	compared	to	in	vivo	experiments,	lens	protein	expression	is	first	noted	in	vivo	around	days	3-6	post-lentectomy	(Day	and	Beck,	2011;	Freeman,	1963),	which	is	consistent	with	the	view	that	CYP26	is	involved	only	prior	to	lens	cell	differentiation.	
	 Given	that	CYP26	activity	is	apparently	important	for	the	earlier	stages	of	regeneration,	we	examined	whether	it	could	play	a	role	in	establishing	or	maintaining	the	ability	of	the	cornea	to	respond	to	molecular	signals	that	trigger	its	differentiation—a	property	known	as	“lens	competence”.	To	this	end	we	assessed	the	expression	of	key	molecular	markers	associated	with	lens	competence,	pax6	and	
fgfr2,	following	CYP26	inhibition	and	RA	addition.	pax6	is	a	transcription	factor	that	regulates	eye	and	lens	development	in	mammals	(Enwright	and	Grainger,	2000)	as	well	as	Xenopus	(Altmann	et	al.,	1997).	Pax6	is	a	hallmark	of	lens	competence	and	initial	lens-forming	bias	in	the	embryo	(Fujiwara	et	al.,	1994;	Li	et	al.,	1994;	Zygar	et	al.,	1998),	and	its	expression	also	demarcates	the	lentogenic	area	of	the	cornea	from	surrounding	lens-incompetent	ectoderm	(Gargioli	et	al.,	2008;	Perry	et	al.,	2013).	Ectopic	misexpression	of	pax6	is	also	sufficient	to	endow	lens-incompetent	ectoderm	with	the	ability	to	respond	to	retinal	factors	and	to	generate	a	new	lens	(Gargioli	et	al.,	2008),	and	work	in	newts	has	shown	that	pax6	is	specifically	involved	in	the	early	stages	of	lens	regeneration,	such	as	cell	proliferation,	rather	than	later	stages	like	lens	fiber	differentiation	(Madhavan	et	al.,	2006).	Given	that	there	is	a	known	interaction	between	pax6	and	RA	(Gajovic	et	al.,	1997),	we	
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additionally	examined	fgfr2.	FGFR2	is	another	competence	marker	that	is	exclusively	expressed	in	lentogenic	ectoderm	of	Xenopus	(Arresta	et	al.,	2005).			 qPCR	analyses	were	done	in	the	same	manner	as	described	above	for	
cyp26a1,	but	the	corneas	here	were	treated	with	either	DMSO,	100µM	Liarozole,	or	20µM	RA.	We	found	that	the	expression	of	pax6	was	greatly	reduced	by	treatment	with	Liarozole	(35%	reduction;	N	=	4;	p	<	0.05),	and	by	RA	(57%	reduction;	N	=	5;	p	=	0.0012)	compared	to	DMSO	treatment	(N	=	5)	(Figure	3.2C).	This	result	shows	that	CYP26	antagonism,	and	any	resultant	increases	in	endogenous	RA,	will	reduce	
pax6	expression	and	thereby	transform	the	cornea	into	a	relatively	more	lens-incompetent	state.	Since	exogenous	RA	also	decreased	the	expression	of	pax6,	it	appears	that	the	effect	that	CYP26	antagonism	had	on	pax6	could	be	due	to	a	rise	in	tissue	RA,	rather	than	a	loss	of	any	RA	metabolite.	Similarly,	exogenous	RA	significantly	reduced	fgfr2	expression	(27%	reduction;	N=3;	p<0.001).	While	Liarozole	treatment	appeared	to	reduce	fgfr2	expression,	the	effect	was	not	statistically	significant	(Figure	3.2C).	The	evidence	suggests	that	the	purpose	of	CYP26	within	the	cornea	could	be	to	maintain	a	lentogenic	state	by	attenuating	RA	signaling.	Although	pax6	is	elsewhere	known	to	have	roles	in	enabling	lens	fiber	cell	differentiation	and	crystallin	expression	(Madhavan	et	al.,	2006;	Shaham	et	al.,	2009),	the	downregulation	of	pax6	observed	here	is	evidently	unable	to	prevent	these	late	events	in	Xenopus	lens	regeneration.	This	further	suggests	a	role	for	CYP26	only	in	early	lens	regeneration	events	only.		 The	action	of	CYP26	is	necessary	within	the	Xenopus	cornea	in	order	for	lens	regeneration	to	occur,	but	the	precise	mechanism	remains	unclear.	The	present	study	however	further	cements	its	importance	as	a	retinoic	acid	metabolizer	and	ablator	of	RA	signaling,	and	provides	insight	into	the	time	period	during	regeneration	in	which	CYP26	is	needed.	Understanding	the	unique	mechanisms	that	allow	a	species	to	regenerate	lens	tissue	broadens	our	understanding	of	the	regenerative	biology	of	the	lens,	and	brings	us	closer	to	developing	therapies	to	replace	our	own	damaged	or	lost	lenses.	
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Figure	3.1	
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Figure	3.1	(cont.)		(A)	The	addition	of	4-oxo-RA	with	Liarozole	does	not	rescue	the	inhibitory	effects	of	CYP26	antagonism.	*	indicates	p	≤	0.001.	(B)	Treatment	of	corneal	tissue	with	4-oxo-RA	leads	to	the	upregulation	of	cyp26a1,	a	marker	of	RA	signaling	activity,	showing	that	the	molecule	has	expected	molecular	effects	in	the	tissue.	*	indicates	p	≤	0.01.	(C,	D,	F,	G)	Fixed	cornea	pelts	are	labeled	with	DAPI	(blue)	and	anti-Histone	H3	antibody	(green)	and	the	number	of	mitotic	figures	are	counted	to	determine	the	amount	of	cell	proliferation	in	control	and	drug-treated	tissues.	White	arrowheads	indicate	mitotic	figures.	Liarozole	treatment	leads	to	diminished	cell	proliferation	(D)	compared	to	controls	(C),	and	exogenous	4-oxo-RA	fails	to	compensate	for	this	effect	(G).	Treatment	of	4-oxo-RA	alone	has	no	effect	on	proliferation	(F).	Scale	bar	in	(G)	equals	50µm.	The	results	are	quantitated	in	(E).	*	indicates	p	≤0.01.	(H)	When	stage	10	gastrulas	are	treated	with	4-oxo-RA,	they	develop	defects	in	the	anterior-posterior	axis;	a	classic	sign	of	aberrant	RA	signaling	(Pijnappel	et	al.,	1993).	Embryos	are	photographed	at	stage	29.	Scale	bar	in	(H)	equals	1mm.	All	error	bars	indicate	standard	error.			
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Figure	3.2		
	
			
(A) Schematic depicting the timing of events in the experimental design. (B) Delaying 
the addition of the CYP26 antagonist Liarozole or RA yields results nearly identical to 
that of the control experiment, where the drugs are added immediately following surgery. 
However, delaying addition by 48 hours results in uninhibited regeneration. * indicates 
p< 0.01, ** indicates p< 0.0001. (C) Real-time quantitative PCR on cornea-derived RNA 
shows that Liarozole and RA treatments both significantly lower the expression of the 
transcription factor pax6. Exogenous RA also significantly lowers the expression of fgfr2. 
* indicates p<0.05, ** indicates p< 0.001. All error bars indicate standard error. 			
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CHAPTER	4	
	
Conclusions	and	Future	Directions			 The	chief	finding	of	this	work	has	been	to	identify	that	CYP26	is	important	during	Xenopus	lens	regeneration,	by	acting	to	inhibit	RA	signaling.	This	most	likely	occurs	during	the	early	stages	of	regeneration.	We	have	described	a	clear	departure	from	newt	regeneration,	highlighting	the	importance	of	assessing	species-specific	differences	when	studying	regenerative	phenomena.	Based	on	the	data,	our	current	operating	model	for	the	role	of	CYP26	and	RA	signaling	in	Xenopus	lens	regeneration	is	that	CYP26	metabolizes	and	eliminates	retinoic	acid	from	the	cornea	early	during	regeneration.	This	attenuates	RA	signaling	in	the	cornea	and	allows	the	tissue	to	adopt	a	lens-competent	state,	characterized	by	the	expression	of	factors	such	as	
fgfr2	and	pax6.	Once	this	state	has	been	established	by	the	action	of	CYP26,	the	cornea	is	capable	of	responding	to	retinal	factors	that	will	trigger	it	to	transform	into	a	lens.		 Our	characterization	of	RA	signaling	within	this	context	expands	our	understanding	of	the	events	that	underlie	corneal	transformation	into	a	lens.	We	have	also	broadened	our	knowledge	of	the	functional	roles	of	CYP26	in	biology.	The	three	most	interesting	questions	that	still	remain	to	be	addressed	by	the	field	in	the	years	ahead	are	suggested	here.	
	
1:	What	genes	are	regulated	by	RA	signaling	in	the	cornea?	
	 RA	signaling	attenuation	is	apparently	important	during	lens	regeneration,	but	it	is	not	clear	what	related	events	this	serves	to	attenuate	or	enhance.	Investigating	which	loci	are	under	the	control	of	RA-mediated	chromatin	remodeling	within	the	regenerating	cornea	can	reveal	currently	unknown	genes	or	regulatory	regions	that	are	a	critical	part	of	regenerating	lenses	de	novo.	Chromatin-
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immunoprecipitation	experiments	using	antibodies	that	target	RAR	proteins	in	cornea-derived	extracts	would	cast	light	upon	such	RA-regulated	loci.		
2:	Does	CYP26	regulate	corneal	cell	division?	Is	this	function	independent	of	
RA	metabolism?	
		 Our	work	demonstrated	that	CYP26	antagonism	would	reduce	cell	division	within	the	cornea,	but	exogenous	RA	could	not	do	the	same.	We	also	showed	that	this	effect	is	not	due	to	a	reduced	production	of	4-oxo-RA	in	the	cornea	upon	CYP26	inhibition.	While	our	work	showed	that	CYP26	antagonism	reduced	corneal	cell	division,	we	have	not	shown	that	CYP26	is	an	endogenous	regulator	of	corneal	cell	division	in	vivo.	Cornea-wide	knockdown	of	CYP26	and	a	subsequent	analysis	of	cell	division	could	confirm	the	relevance	of	CYP26	in	this	context.	Taken	together	with	the	findings	from	our	work,	it	would	suggest	a	role	for	CYP26	that	is	independent	from	its	role	as	an	RA	metabolizer	and	regulator	of	RA	signaling.	This	hypothesis	warrants	further	biochemical	examination,	perhaps	using	mutant	CYP26	proteins	with	inert	active	sites.	A	discovery	of	a	novel	non-enzymatic	role	for	CYP26	would	be	a	highly	significant	finding	even	outside	of	the	field	of	regenerative	biology.		
3:	Is	CYP26	also	relevant	in	Xenopus	during	lens	development	from	surface	
ectoderm?			 While	we	were	able	to	describe	a	previously	unknown	role	for	CYP26	during	lens	regeneration,	it	remains	unclear	whether	the	same	role	is	relevant	in	the	course	of	lens	development.	In	particular,	experimental	inhibition	or	knockdown	of	endogenous	CYP26	in	the	lens	placode	has	not	been	done	to	assess	whether	it	is	necessary	to	develop	a	lens.	If	interference	of	CYP26	during	lens	development	should	lead	to	aphakia,	the	result	would	be	congruent	with	the	findings	of	our	research,	and	highlight	the	common	ground	that	exists	between	lens	development	and	regeneration.	Likewise,	the	opposite	finding	would	reveal	a	distinction	between	the	two	schemes,	and	highlight	the	unique	processes	that	underlie	regeneration.	
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While	we	have	learned	a	great	deal	about	the	regenerative	biology	of	
Xenopus,	much	work	remains	to	be	done	to	fully	understand	cornea-lens	regeneration,	and	more	work	remains	to	be	done	before	we	may	translate	such	findings	into	clinical	medicine.																												
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APPENDIX	
	
Method	for	an	ex	vivo	lens	regeneration	assay	in	Xenopus	laevis	larvae	
	 The	use	of	an	ex	vivo	eye	culturing	system,	first	described	in	2011	(Fukui	and	Henry,	2011),	allows	for	the	effects	of	pharmacological	agents	to	be	isolated	to	the	cultured	tissues,	and	allows	the	usage	of	very	small	amounts	of	limited	or	expensive	compounds.	In	the	example	protocol	described	below,	we	will	consider	a	hypothetical	compound	“Drug	X”	and	its	corresponding	control	dimethyl	sulfoxide	(DMSO),	the	solvent	in	which	Drug	X	is	dissolved.		
A.1	Selection	of	animals	
	 Animals	staged	48-52	are	ideal	for	experiments,	as	they	are	large	enough	to	perform	surgery	upon	and	immature	enough	to	have	the	ability	to	regenerate	lenses	in	vivo.	Staging	is	performed	according	to	Nieuwkoop	and	Faber,	1956.	Animals	are	readily	identified	at	stage	48	when	they	first	acquire	an	iridescent	cover	over	their	abdomen,	and	at	stage	52	when	they	begin	to	form	digits	on	their	limbs.		When	experiments	are	repeated,	the	embryos	in	the	repeat	experiments	are	the	offspring	of	a	unique	pairing	of	two	different	parents.	Thus,	animals	used	in	different	experiments	are	never	siblings,	but	may	be	half-siblings.	Animals	with	gross	defects	(e.g.,	ocular	coloboma,	albinism,	scoliosis,	bloating,	etc.)	are	not	selected	for	experiments.		
A.2	Preparation	of	culture	media	
	 The	culture	media	used	in	ex	vivo	lens	regeneration	assays	is	known	as	modified	L-15	(mL15)	media.	To	prepare	500mL	of	mL15	medial,	dissolve	4.18g	of	L-15	powder	(Gibco,	Waltham,	MA)	into	approximately	450mL	of	cell-culture	
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been	exposed	to	detergents	of	any	kind.	It	is	advisable	to	reserve	a	1L	bottle	exclusively	for	this	use.	Add	50mL	of	fetal	bovine	serum	(10%	of	final	volume).	Adjust	the	pH	of	the	solution	to	7.5-7.6	and	adjust	the	final	volume	to	500mL.	Filter-purify	the	media	using	a	0.2µm	filter	under	a	laminar	flow	hood,	making	sure	again	that	the	filtered	media	goes	into	a	sterile	bottle	that	has	never	been	cleaned	with	detergents.	Aliquot	the	media	into	50mL	aliquots	in	sterile	tubes	and	store	them	at	4ºC.	Media	stored	in	this	manner	may	be	used	for	up	to	4	months.		Before	initiation	of	an	experiment,	add	the	following	antibiotics	and	antifungal	agent	to	an	individual	mL15	aliquot	so	as	to	achieve	final	concentrations	of:	10kU/mL	penicillin-streptomycin,	4µg/mL	Marbofloxacin,	and	2.5µg/mL	Amphotericin	B.	Once	antimicrobials	have	been	added,	the	media	may	be	used	for	up	to	3	weeks	when	stored	at	4ºC.	Before	the	media	may	be	used	in	an	experiment,	it	must	be	brought	to	room	temperature.		
A.3	Anesthesia	and	Surgery	
	 Three	to	six	animals	of	the	appropriate	stages	are	anesthetized	at	once	in	a	small	petri	dish	filled	with	3-5	mLs	of	anesthetic	solution.	The	anesthetic	used	is	a	1:2000	preparation	of	MS-222	(Sigma,	St.Louis,	MO)	diluted	in	normal	amphibian	media	(NAM):	110	mM	NaCl,	2	mM	KCl,	1	mM	Ca(NO3)2,	l	mM	MgSO4,	0.l	mM	EDTA,	l	mM	NaHCO3,	2	mM	Na	phosphate,	pH	7.4	(Slack,	1984).	Animals	are	transferred	directly	from	their	aquarium	into	the	anesthetic	and	one	must	wait	until	they	are	completely	immobilized	(which	usually	takes	2-4	minutes)	before	transferring	them	into	the	surgical	plate	for	surgery.	Animals	are	transferred	from	dish	to	dish	using	a	large	bore	plastic	transfer	pipet	with	the	distal	end	cut	off	in	such	a	manner	to	accommodate	the	size	of	the	animal.	Alternatively,	a	small	metal	tea	strainer	can	be	used	as	a	net.	The	surgical	dish	contains	soft	modeling	clay	(Van	Aken,	North	Charleston,	SC)	in	which	a	trough	can	be	molded	to	stabilize	the	anesthetized	animal	on	its	side	while	performing	surgery	on	that	side.	The	dish	is	filled	with	enough	
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anesthetic	solution	to	cover	the	animal,	and	surgeries	are	performed	under	a	dissection	microscope.			A	curved	incision	is	created	using	precision	micro-scissors	on	the	posterior-ventral	edge	of	the	outer	cornea,	taking	care	not	to	make	cuts	outside	of	the	pericorneal	area.	The	pericorneal	area	is	the	ring	of	ectoderm	that	extends	1.5x	the	diameter	of	the	eye,	and	does	not	immediately	overlie	the	orb	of	the	eye.	The	incision	should	span	roughly	20-40%	of	the	circumference	of	the	eye.	The	scissors	are	then	inserted	through	this	incision	and	used	to	pierce	the	inner	cornea	at	the	edge	of	the	iris	and	into	the	pupillary	opening	with	a	downward	motion	of	a	single	scissor	blade.	Care	must	be	used	for	if	the	iris	becomes	lacerated	with	this	maneuver,	bleeding	will	occur,	in	which	case	the	surgery	must	be	aborted	and	the	animal	sacrificed.		Once	both	the	outer	and	inner	corneas	have	been	cut,	insert	fine	forceps	into	the	eye	and	to	grab	the	lens.	Pull	out	the	lens	through	the	incisions	and	discard	the	lens	by	wiping	the	tip	of	the	forceps	thoroughly	with	a	Kimwipe,	so	as	to	ensure	no	residual	lens	cells	are	left	behind	on	the	instrument.	Care	must	be	exercised	to	remove	the	entire	intact	lens.	Once	this	is	accomplished,	cut	the	outer	cornea	all	the	way	around	the	circumference	of	the	eye,	again	staying	within	the	boundaries	of	the	pericorneal	area.	The	outer	cornea	should	be	left	attached	to	the	inner	cornea	via	the	central	stalk.	Using	forceps,	insert	the	outer	cornea	into	the	vitreous	chamber	of	the	eye.	Make	sure	the	tissue	remains	inside	the	vitreous	chamber	as	the	forceps	are	released	and	removed	from	the	eye.	Remove	the	whole	eye	from	the	animal	by	cutting	beneath	the	eye	to	sever	the	optic	muscle,	artery	and	nerve	connections.	Transfer	the	eye	into	a	35	mm	petri	dish	containing	2mL	of	mL15	media	(Fig.	A.1).		The	transfer	of	eyes	is	done	using	a	P200	micro-pipet	with	the	distal	ends	of	the	pipet	tip	cut	off.	Barrier	pipet	tips	(Denville	Scientific,	South	Plainfield,	NJ)	are	cut	with	a	razor	blade	and	then	autoclaved.	The	tips	are	cut	to	create	an	opening	
  88 
large	enough	to	accommodate	the	size	of	the	eyeballs,	but	narrow	enough	to	still	allow	some	capillary	action,	which	helps	to	retain	the	eye	during	transfer.			 Turn	the	animal	onto	the	other	side	and	repeat	the	lentectomy	(lens	removal	from	the	eye)	and	enucleation	(eye	removal	from	the	body)	procedures.	After	the	eyes	have	been	transferred	into	the	dish	containing	mL15	media,	transfer	them	once	more	into	an	identical	dish	of	fresh	media	to	“wash”	them.	After	3-5	minutes,	swirl	them	around	and	randomly	transfer	one	eye	rach	each	into	another	35	mm	petri	dish	containing	2mLs	of	either	DMSO-containing	control	media	or	media	containing	Drug	X.	This	step	is	to	ensure	unbiased	and	random	allocation	of	eyes	into	experimental	and	control	groups.	The	wash	dishes	and	media	should	be	replaced	after	24-30	eyes	have	been	rinsed	in	them.			The	enucleated	animal	is	euthanized	by	leaving	it	in	a	separate	dish	of	MS-222	for	2	hours,	and	stored	at	-20ºC	thereafter.		
A.4	Ex	vivo	culturing	
	 After	all	lentectomized	eyes	have	been	collected	into	the	extra	small	petri	dishes	with	DMSO	or	Drug	X-containing	mL15,	each	eye	is	transferred	into	an	individual	well	of	a	24-well	polystyrene	cell	culture	plate,	with	each	circular	well	having	a	radius	of	0.77cm.	Wells	are	filled	with	350µL	of	appropriate	media	and	one	eye	is	allocated	to	each	well.	Isolation	of	eyes	in	this	manner	prevents	fusion	of	eyes	that	occurs	when	cultured	in	clusters,	and	it	minimizes	the	spread	of	potential	microbial	contamination.	Once	all	eyes	are	placed	into	the	24-well	plate,	the	plate	is	placed	inside	of	a	“moisture	chamber”—	a	small,	covered,	plastic	box	with	a	moistened	sponge	placed	inside—to	minimize	evaporation	of	the	media.	The	culturing	is	done	at	ambient	temperature	(18-24ºC).	If	any	drug	being	used	is	sensitive	to	light	(for	instance,	retinoids)	then	the	moisture	chamber	is	placed	in	a	dark	container	or	drawer.		
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The	day	that	surgeries	are	performed	is	denoted	as	“Day	0”,	and	subsequent	days	are	denoted	“Day	1,	Day	2…”	etc.	The	culture	media	is	changed	every	other	day	(on	even	numbered	days)	by	pipetting	out	the	350µL	in	each	well	and	replacing	it	with	appropriate	fresh	media.	All	changes	of	media	should	take	place	under	a	laminar	flow	hood,	and	one	should	exercise	proper	asceptic	technique.	The	eyes	should	be	monitored	daily	for	microbial	contamination.	Contamination	can	be	seen	if	there	is	a	change	in	the	color	of	the	media	to	orange,	yellow,	or	purple,	if	the	media	appears	turbid,	or	if	fungal	hyphae	are	seen	growing	on	or	around	the	eyes.	If	contamination	is	present	in	any	well,	all	contents	of	that	well	should	be	discarded,	and	all	remaining	eyes	should	be	transferred	to	a	new,	clean	24-well	plate.	If	any	eyes	appear	grossly	damaged	in	the	days	following	surgery,	those	eyes	should	be	discarded.		
	
Figure	A.1	
Illustration	from	Fukui	and	Henry,	2011.			
A.5	Fixation	and	histological	preparation	
	 Ex	vivo	culturing	is	terminated	on	Day	7	by	transferring	eyes	from	their	wells	into	a	35	mm	petri	dish	containing	2mL	of	PBS.	If	the	eyes	have	become	adhered	to	the	bottom	of	the	culture	well,	they	can	be	displaced	by	repeatedly	aspirating	the	media	around	the	eye	with	a	pipet,	or	they	can	be	gently	lifted	off	the	surface	using	a	fine	pipet	tip.	They	are	swirled	in	the	dish	gently	for	2-3	seconds	to	rinse	off	mL15	media	from	their	surface.	They	are	then	immediately	transferred	into	a	small	glass	vial	containing	4mL	of	fixative.	The	best	fixation	method	to	use	depends	on	the	
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antibody	or	staining	method	being	used	later,	and	it	should	be	determined	empirically.			 Typically,	eyes	are	assessed	for	lens	regeneration	via	an	anti-lens	antibody	(see	section	A.6),	and	so	they	are	fixed	for	30	minutes	in	3.7%	formaldehyde	at	room	temperature.	They	are	prepared	for	thin	sectioning	by	embedding	them	in	paraffin	wax,	following	standard	protocols	for	paraffin-section	immunohistochemistry.	In	brief:	the	fixative	is	replaced	with	PBS	and	eyes	are	incubated	for	10	minutes	at	room	temperature.	These	rinses	are	repeated	two	more	times.	The	eyes	are	then	carried	through	a	series	of	dehydrating	washes,	each	step	being	10	minutes	long	and	each	wash	having	a	volume	of	about	5mLs:	30%		ethyl	alcohol	(EtOH),	50%	EtOH,	70%	EtOH,	95%	EtOH,	100%	EtOH.	The	alcohol	dilutions	are	made	in	deionized	water.	After	the	final	wash,	the	EtOH	is	replaced	with	fresh	100%	EtOH	and	it	is	incubated	at	room	temperature	for	1	hour.	Then,	it	is	replaced	with	a	50/50	mixture	of	Xylenes	and	EtOH	and	incubated	for	10	minutes	before	performing	two	10-minutes	washes	with	100%	Xylenes.	The	Xylenes	are	replaced	with	melted	paraffin	wax	(Paraplast	Plus)	in	an	oven	at	59ºC,	and	eyes	are	embedded	into	blocks	of	wax	and	sectioned	into	10µm	thick	sections	and	placed	on	charged	glass	slides	(Colorfrost	Plus,	Thermo	Scientific,	Kalamazoo,	MI)	using	deionized	water.	The	water	is	removed	from	the	slides	by	placing	them	on	a	slide-warming	tray	at	32ºC	overnight.			
A.6	Immunohistochemistry,	and	lens	scoring	criteria	
	 Prior	to	beginning	the	staining	and	scoring	of	regenerated	lenses,	each	specimen	should	be	anonymized	so	as	to	allow	an	objective	and	blinded	assessment	of	cases	of	positive	lens	regeneration.	This	is	typically	done	by	renaming	each	paraffin	block	with	a	randomly	assigned	letter,	making	note	of	what	each	letter	corresponds	to	in	a	separately	prepared	key.	The	new	letter	designation	is	carried	over	throughout	all	subsequent	steps	in	the	experiment,	blinding	the	experimenter	to	the	identity	of	each	specimen	as	they	section,	stain,	and	score	them.	After	all	
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scoring	has	been	done	the	experimenter	can	refer	to	the	key	to	identify	how	many	cases	of	regeneration	are	seen	in	any	given	experimental	or	control	group.		 Immunohistochemical	(IHC)	staining	is	performed	per	standard	IHC	protocols	with	slight	modifications.	The	slides	are	stained	with	1:500	polyclonal	anti-lens	antibody	(Henry	and	Grainger,	1987)	for	1	hour	at	room	temperature.	It	is	then	stained	with	an	appropriate	secondary	antibody	(typically	a	goat-anti-rabbit-Alexa	488,	1:300)	for	2	hours	at	room	temperature.	Coverslips	are	added	using	a	preparation	of	80%	glycerol/	20%	PBS.	A	positive	case	of	lens	regeneration	is	identified	when	there	is	a	round	area	of	tissue	that	stains	with	discernable	fluorescent	signal.	The	scoring	of	each	case	of	regeneration	is	binary,	and	is	neither	qualitative	nor	quantitative	when	assessed	in	paraffin	sections.		
A.7	Statistical	analysis	
	 	 No.	of	eyes	that	did	regenerate	a	lens	 No.	of	eyes	that	did	NOT	regenerate	a	lens	
Total	
DMSO	treatment	 A	 B	 A	+	B	
Small	molecule	treatment	 C	 D	 C	+	D	
Total	 A	+	C	 B	+	D	 N		
p	=		(A+B)!(C+D)!(A+C)!(B+D)!	A!B!C!D!N!	
	 The	Fisher’s	Exact	statistical	test	is	used	here	to	determine	the	significance	of	observed	deviation	between	regeneration	rates	in	control,	and	drug-treated	eye	cultures.	It	is	better	suited	than	the	Χ2	test	for	small	sample	sizes.	Additionally,	a	Χ2	test	requires	that	every	value	in	the	table	above	be	greater	than	10,	as	there	is	1	
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degree	of	freedom	in	this	application	of	the	test	(Pagano	and	Gauvreau,	2000).	As	such,	the	test	is	not	suitable	for	use	when	an	inhibitor	is	very	potent	at	inhibiting	lens	regeneration,	resulting	in	fewer	than	10	eyes	with	regenerated	lenses.	The	Fisher’s	Exact	test	has	no	such	requirement	and	can	therefore	be	applied	to	data	from	experiments	using	strong	inhibitors.	A	two-tailed	p-value	calculation	will	evaluate	whether	there	is	a	difference	between	regeneration	rates	between	two	groups,	without	any	assumption	as	to	whether	the	drug-treated	group	should	have	a	lower	or	higher	regeneration	rate	than	the	DMSO-treated	control	group.	A	p-value	<0.05	is	considered	as	statistically	significant.																								
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